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Abstract
A Monte Carlo model was developed to determine the cost-effectiveness of different
biosecurity strategies for Bovine Viral Diarrhea Virus (BVDV) on cow-calf farms. Where
possible, risk distributions were defined in the course of a critical literature review covering all
publications since 1990 relevant to BVDV on cow-calf farms. The prevalence of persistent
infections (PIs) in adult cows was unknown, so a survey of viremia in 2,990 adult cows for sale
in the Midwest during 2006 was performed; prevalence was calculated to be 0.07%. In order to
validate a newly developed RT-nPCR for pooled serum used for the survey, sensitivity was
determined based on 100 known viremic serum samples; sensitivity was 95%, with no detectable
effect of strain type.
A Monte Carlo model was developed to calculate the risk of introducing BVDV to a
cow-calf herd and number of PIs introduced in one year, based on herd imports and biosecurity
strategies. The results of that model were integrated with a stochastic SIR model for the spread
and impact of BVDV through a cow-calf herd over 10 years, based on herd size and control
strategies. The resulting model was integrated with a stochastic model for the cost of both the
biosecurity and control measures used and the financial impact of BVDV infection on the herd
over 10 years. The lowest risk option of 14 biosecurity strategies were calculated for 400-, 100-,
and 50-head herds with 8 different import profiles, and management factors that increase
financial risk due to BVDV were determined.
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1CHAPTER 1 - A critical literature review of bovine viral diarrhea
virus risk of introduction and spread on US cow-calf farms
Abstract
Bovine Viral Diarrhea Virus is a major source of economic loss in the cattle production
industry. Sources of infection introduction for cow-calf producers are primarily imported cattle
and infected contact herds. Importation risk may be decreased by testing and quarantine
schemes, while vaccination can decrease spread after initial infection. The impact of infection
on the cow-calf herd includes reproductive effects and increased calf morbidity and mortality.
Identifying the risk factors leading to herd infection allows control strategies to be designed.
Establishing infection dynamics, impacts, and mitigation factors permit risk analysis models to
evaluate those strategies.
Introduction
Bovine viral diarrhea (BVD) was first described in 1946 (Olafson et al., 1946) as a
pathogen of cattle, causing diarrhea, abortion, and immunosuppression leading to respiratory
disease. The disease is caused by Bovine Viral Diarrhea Virus (BVDV), a single-stranded RNA
virus in the family Flaviviridae. Transmission occurs via secretion in nasolacrimal fluid and
other bodily fluids. All ages are susceptible, but symptoms and outcomes vary; adults primarily
exhibit reproductive effects, while youngstock experience the bulk of morbidity and mortality.
In addition, calves infected between 40 and 125 days gestation with noncytopathic virus may
become persistently infected (PI) (Stokstad and Loken, 2002), resulting in persistent shedding
of virus in large quantities.
The BVD virus causes major production losses in the cattle industry and is endemic in
much of the world. The exceptions to this are several European countries with advanced
eradication programs. Success in control and eradication approaches, especially in Scandinavia
(Valle et al., 2005; Hult and Lindberg, 2005), have shown that such programs are effective. In
order to develop a useful control program for BVDV in the cow-calf industry, it is necessary to
understand the components of the disease risk and the means of controlling those risk factors.
2Risk analyses have proved a valuable tool in identifying critical control points and the economic
benefits of various disease interventions (Valle et al., 2005). The purpose of this critical
literature review is to collate and present pertinent information towards the development of a risk
analysis model for BVD introduction and transmission within US beef cow-calf industry.
Methods
A systematic literature review was performed using the CAB, Pub-Med, and Agricola
databases for all journal articles between 1990 and the present referencing the keywords BVD,
BVDV, bovine viral diarrhea, and bovine viral diarrhoea. The search period was bracketed at
1990 because understanding of the virus and its mode of action was limited previous to that time
and the research performed was considered to be of little use for the present purposes. Pertinent
journal articles presenting original research, obtainable by the Kansas State University library
system and its partner system, and written in English, Spanish, or French, have been critically
reviewed. The information obtained has been compiled to provide an accurate picture of the
current state of knowledge of the epidemiology of BVD in beef cattle. In addition, a few journal
articles that precede 1990 were included to provide necessary background information. Gaps in
the knowledge base were identified for further study. References were reviewed critically by a
single reader, using checklists developed for each study type. Quality was assessed by the
number of applicable checkpoints met.
Results
Sources of BVD Infection
Prevention of BVDV introduction to beef cow-calf farms currently free of the virus, as
well as for preventing re-introduction during control programs, requires identification of sources
of infection and the risk associated with each. Although there are many sources of virus
introduction documented in the literature, the majority of the risk comes from a few main
sources, as described below.
Numerous successful control policies have established imported cattle by as the primary
risk factor for introduction of BVDV to a herd (Valle et al., 1999; Schaik et al., 2002;
Obritzhauser et al., 2005; Solis-Calderon et al., 2005). Imported cattle may be persistently
infected (PI) animals (Confer et al., 2005) or animals pregnant with PI fetuses (Bitsch et al.,
32000), either of which adds a constant source of BVDV to the herd population, making high
levels of transmission and chronic herd infection (Cherry et al., 1998) a possibility. PI animals
are highly viremic in most cases, although they may not consistently shed high amounts of virus
(Waxweiler et al., 1991). Transiently infected (TI) animals may introduce BVDV to a herd
(Moen et al., 2005), but the viremias are low in contrast to PI animals so TI animals are often
considered to be a low comparative risk for BVD importation (Niskanen et al., 2002b).
(Valle et al., 1999) found importation to be non-significant in herd BVDV infection
status, but this study was performed near the end stages of a nation-wide eradication scheme and
may have been biased by the successfully lowered prevalence in the general population. In the
US, where a nationwide control policy does not exist, the advantage of importing from known
negative herds is unavailable. Barring a closed herd, then, the best way to control importation
risk has been assumed to be effective testing and quarantine (Hult and Lindberg, 2005; Joly et
al., 2005).
Although the primary source of BVDV introduction seems to be imported animals, other
sources of virus are possible. The spread of BVDV from neighboring herds is also a major
concern, especially in herds on pasture (Houe et al., 1995a; Valle et al., 2000). Communal
pasture use is a high risk activity (Braun et al., 1999; Valle et al., 1999; Bitsch et al., 2000;
Schaik et al., 2002; Obritzhauser et al., 2005; Siegwart et al., 2006) unless the status of the other
herds is known to be BVDV-negative. In effect, sharing pasture with an infected herd is
equivalent to having infection within one’s own herd, as free mixing of animals allows PI
animals direct contact without regards for ownership. One model of disease risk, in a European
setting, found that herds which shared pasture with other herds were 5.1 times as likely to be
seropositive for BVD as those who did not share pasture (Valle et al., 1999).
Fenceline contact with neighboring herds is also a risk for BVDV introduction (Desilets
et al., 1996; Valle et al., 1999; Bitsch et al., 2000; Campen et al., 2000; Ross, 2003), as direct
contact between cattle can occur through fences and on the occasion of fence breaks. No
published studies of fenceline contact risk are applicable to US cow-calf farms, but anecdotal
evidence points to infection of some few herds via fenceline contact.
Other possible sources of BVDV infection, less commonly considered, include semen
(Paton et al., 1990; Kirkland et al., 1991; Voges et al., 1998; Niskanen et al., 2002a), embryo
transfer (Brock et al., 1991; Tsuboi and Imada, 1998), contaminated vaccine (Falcone et al.,
42003), and environmental contamination (Niskanen and Lindberg, 2003; Lindberg et al., 2004).
Semen may be a risk factor if artificial insemination (AI) bulls are infected, as was found to be
true in 1990 (Howard et al., 1990) at 4 AI centers in the US. However, testing procedures at AI
centers are likely to have been implemented in the years since that study, and the risk is almost
certainly very small. Likewise, embryo transfer was a risk factor in the past, but embryo
washing techniques suggested by the International Embryo Transfer Society (, 1998) limit the
risk. Vaccine is a possible source of virus when prepared with serum from PI fetuses (Bolin et
al., 1991), but testing of fetal bovine serum lots by the veterinary biologics industry prevents
contamination. Environmental infection has been observed only when the environment was
reinhabited after short time periods, and so may be controlled by vacancy periods. Fomites such
as rectal sleeves (Lang-Ree et al., 1994), needles and nose-tongs (Gunn, 1993), contaminated
bottles used for injectables (Niskanen and Lindberg, 2003; Katholm and Houe, 2006), and
clothing (Schaik et al., 2002) are also considered to be capable of transmitting BVDV to
susceptible animals. However, most of these infection sources required the close presence of PI
animals to provide recent contamination; others may be controlled through basic biosecurity
measures such as cleaning and disinfection, foot baths, protective clothing for farm visitors, and
appropriate use of fresh rectal sleeves, medicine bottles, and needles for each farm.
Other animals may also be infected by the virus. Species found to carry BVDV or a
related virus naturally or experimentally include wild ruminants, such as deer (Corn et al., 1990;
Braun et al., 1998; Uttenthal et al., 2005), and other livestock species such as llamas (Carman et
al., 2005; Foster et al., 2005; Mattson et al., 2006), swine (Liess and Moennig, 1990), and bison
(Deregt et al., 2005). No transmission of BVDV from other infected species to cattle has been
validated, although cross-species transmission has not been disproven. The risk of transmission
from wild ruminants is completely unknown, as no data exist as to the prevalence of BVDV in
these populations or their capability in transmitting the virus. BVDV has also been detected in
some insects, such as face flies (Gunn, 1993), and transmission from biting flies has been
confirmed in a laboratory setting (Tarry et al., 1991). Controls necessary to decrease infection
from fenceline contact with neighboring herds, such as double fences and avoiding adjacent
pastures during the risk period, likely would be efficacious against insect and other livestock
sources as well.
5Prevalence of BVDV
The risk of introducing BVD by way of imported cattle, the primary risk noted above,
depends on virus prevalence in the cattle imported. The prevalence varies between age groups of
cattle (Hietala et al., 2001), as PI animals experience higher rates of mortality and lower life
expectancy (Houe, 1993). Younger animals will represent a higher risk of PI introduction, as
will pregnant animals through the prevalence of persistent infection of the fetus in utero. Within
herd management practices of the source herd also may impact import risk, as herds with good
control strategies are less likely to be infected. In the various control and eradication programs
in Europe, sourcing animals from certified BVDV negative herds has enabled safe purchase
(Valle et al., 2005; Hult and Lindberg, 2005; Joly et al., 2005) and communal grazing
(Rossmanith et al., 2005) of animals.
Variation in prevalence estimation requires knowledge of the specific class and source of
cattle tested and the diagnostic test used. There are studies estimating prevalence of BVDV in
feeder calves (Taylor et al., 1995; Fulton et al., 2000; Loneragen et al., 2005) and bulls (Howard
et al., 1990; Cleveland, 2003; Givens et al., 2003b; Gnad et al., 2005), as well as herd prevalence
(Wittum et al., 1997; Wittum et al., 2001), for the US beef population. While all the studies
above involve convenience samples, they provide an acceptable estimate of PI prevalence.
Similar information for fetuses, baby calves, heifers, and cows is not as available. It has been
shown that approximately 81% of fetuses will become persistently infected if their dam is
transiently infected during the risk period of 74 and 82 days gestation and it is assumed that this
risk period extends to 120 days, which is the onset of fetal immunity (Stokstad and Loken, 2002;
Stokstad et al., 2003). For the birth of PI calves, then, transient infection must occur during the
risk period, so information on the incidence of TIs in at-risk dams would give an indication of
the fetal and calf prevalence. The incidence of transient infections in all cattle is unknown,
however, as is the incidence during the risk period. Logically, fetal prevalence of BVDV must
be no less than baby calf prevalence, and is likely somewhat lower due to the higher mortality
rates in PI calves. Calf prevalence has been estimated, but with questionable results due to loss
to follow-up (Wittum et al., 2001; Cleveland, 2003); only 72% of calves were available for
retesting, and it is possible that some of the mortalities in the calves lost to follow up were PI and
would have raised the prevalence estimate. The single estimate of heifer prevalence, likewise,
was marred by excessive loss to follow-up and, more importantly, a lack of external validity
6(Cleveland, 2003). Only one herd, with three management groups, was tested, so the heifer
prevalence has little bearing on the national population. Adult cow prevalence estimates are
limited to a single research report, stating a failure to detect any PIs in a sample of 1000 (White
et al., 2007). Determination of the proportions of PI fetuses, calves, cows and heifers within the
beef industry is important to production of a accurate assessment of risk, as these compromise a
significant portion of the imports to cow-calf herds.
A study of 2,000 auction market-derived yearling steers in one feedlot found a 0.3%
prevalence, with a 95% confidence interval (CI) of 0.14-0.65% (Loneragen et al., 2005). A
smaller study, of 938 feeder calves entering two stocker operations, found a prevalence of 0.33%
with a 95% CI of 0.299-0.360% (Larson et al., 2005). However, diagnosis in both studies relied
on the specificity of skin biopsy IHC to PI animals, which has a questionable specificity to
persistent infections (see below, under Testing), and may have overestimated the prevalence.
Fulton et al. examined over 21,000 500-pound calves entering a Kansas feedlot from order
buyers in several southern and southeastern states and found a PI prevalence of 0.40% (Fulton et
al., 2006). However, the follow-up test was performed after only 48 hours, and viremia has been
noted in transiently infected animals for more than 10 days (Patel et al., 2002). The animals in
the study by Fulton et al. may have become TI during transit, so the prevalence figure may be
overestimated. In 1,045 feedlot calves, part of a group of 5,129 seven to ten month old calves
from a variety of auction markets in Western Canada, only one was viremic, and it was lost to
follow-up before being diagnosed as persistently infected (Taylor et al., 1995). The occurrence
of mucosal disease in the unsampled calves led the authors to infer a prevalence between 0 and
0.1%.
A study of young purebred bulls in Kansas, using samples from all bulls offered for
public or private sale in one year, found a BVDV prevalence of 0.67%, with 95% CI of 0.35-
0.99% (Gnad et al., 2005), based on 2,520 serum samples. An immunoperoxidase monolayer
microtiter assay was used for testing, which has no established sensitivity or specificity on serum
samples in the published literature. The study only included breeding bulls sold in the state of
Kansas, but all animals <2 years of age sold during the year 2001 were included. No follow-up
was performed, so some of the animals may have been TI and this would bias the results to a
higher prevalence estimate.
7Beef herd prevalence overall has been estimated to be 3.75%, with a 95% CI of 0.26%-
7.24% (Wittum et al., 1997) in 80 randomly selected herds with at least 20 breeding females.
Serum was collected from all calves in the herds and an immunoperoxidase monolayer microtiter
assay was used for testing, although the sensitivity of this test has not been validated in the
published literature. The study focused on commercial beef herds and used a geographically
diverse sample. Based on 76 randomly selected herds from the same study (Wittum et al.,
2001), herd prevalence was estimated at 3.95% with a 95% CI of 0.27%-7.62%. No reason was
given for excluding 4 herds previously included, but it appears they were reclassified as suspect
herds, rather than randomly selected. In BVDV suspect herds, the estimate is higher, with herd
prevalence estimates ranging from 10%,(10/100 herds), in diagnostic laboratory submissions in
Ontario (Alves et al., 1996), to as high as 19.2% or 10 in 52 herds (Wittum et al., 2001). Risk of
virus introduction, therefore, is higher from herds showing signs of BVDV infection.
Testing
Testing imported cattle, including calves of pregnant imports is one method of decreasing
risk of BVD introduction. Numerous tests are available for detection of virus, including virus
isolation, antigen capture ELISA, IHC and PCR for detection of BVDV (Table 1).
Table 1.1: Tests currently available for BVDV
Test Cost Sensitivity Pool Sensitivity Sample types possible
VI Moderate to
high
0.64-1.0 N/A Whole blood, serum, tissue
IHC Low 0.97-1.0 N/A Whole blood, tissue
ELISA Low 0.47-1.0 N/A Whole blood, serum, tissue
PCR Moderate to
high
0.9-1.0 1.0 (Kennedy et al.,
2006)
Whole blood, serum, tissue
supernatent
Microplate
VI
Moderate 0.5-0.85 N/A Serum
8Virus isolation (VI) is considered the gold standard by most studies of other tests (Frey et
al., 1991; Mignon et al., 1992; Deregt and Prins, 1998; Ozkul et al., 2002; Cornish et al., 2005;
Walz et al., 2005)). As such, few studies discuss its sensitivity or specificity. The few studies
found in this review that did examine the effectiveness of VI were all of similar quality. Older
studies tend to report high specificity with mediocre sensitivity of 83% on 1006 buffy coat
samples from 989 6-month old steers (Mignon et al., 1992) and 83% on liver and kidney tissue
from 105 aborted fetuses (Ellis et al., 1995). More recent studies, however, with improved
techniques, report higher sensitivities on buffy coat samples, with correct identification of 41 of
45 samples (91%) previously established as BVDV-positive and 15 of 15 negative controls
(Ozkul et al., 2002). In an unpublished study, VI detected 30 of 41 calves (73%) identified as PI
by one of five diagnostic tests with 100% specificity on 782 samples negative by all five tests
(Walz et al., 2005).
Microplate virus isolation, as a cheaper and faster method, has been applied to some
extent on serum. One study on serum, buffy coat, and tissue homogeonate found 85% sensitivity
and 100% specificity when compared to VI, although data on the sensitivity to different samples
was not made available (Saliki et al., 1997). An unpublished study found only 50% sensitivity
on serum, however, with 100% specificity (Walz et al., 2005). Further investigation is indicated.
Opinions as to the usefulness of ELISA tests vary by sample type and report. One study
examined the performace of four different ELISA tests on buffy coat samples compared to full
plate virus isolation. Each test exhibited 100% specificity. Three of the tests were highly
sensitive (range 94-97%) but one test was only 64% sensitive (Brinkhof et al., 1996). No
explanation was given for the low sensitivity of the one test. Two older studies found 100%
sensitivity and specificity (Mignon et al., 1992) and 97% sensitivity and 99% specificity
(Sandvik and Krogsrud, 1995) on buffy coat samples. Another study compared the sensitivity
and specificity of ELISA to BVDV on supernatent from skin samples with VI results on tissue
and buffy coat samples from the same animals, finding 100% sensitivity and 98% specificity
(Cornish et al., 2005), but the samples included were entirely from viremic animals, with a few
TI animals and mostly PI animals. A study including both confirmed PI animals and field
samples from certified BVDV-free herds found 100% sensitivity and 99.6% specificity (Kuhne
et al., 2005) and gives more confidence in the specificity estimate, as a greater variety of non-PI
9animals was included. Serum samples, by comparison, seem to have a low sensitivity when
compared to VI. Graham et al. (Graham et al., 1998a) estimated 46-48% sensitivity and
specificity of 95% in 214 field samples from BVDV-suspect animals. Saliki et al. (Saliki et al.,
1997) found 85% sensitivity with 100% specificity with 224 field samples and 30 titrated virus
samples. In these two studies of ELISA on serum samples, the gold standard was held to be VI,
which has a low sensitivity with serum samples, as noted above. The estimated ELISA
sensitivity may be too high, in consequence, and the specificity may be too low, as some of the
samples may have been misclassified by the VI. Another study, however, found sensitivity and
specificity of 100% on serum samples from 30 PIs and 30 negative controls previously
established by VI (Plavsic and Prodafikas, 2001), which provided a more appropriate measure of
infection status based on multiple test resultss.
Rt-PCR is frequently used on several types of samples. Early studies found that PCR was
able to identify multiple strains in both serum and tissue homogeonates (Belak and Ballagi-
Pordany, 1991), with sensitivity that may exceed that of VI (Uruno et al., 1998). Newer studies
have found 100% sensitivity on whole blood (Deregt et al., 2002) and 93% sensitivity on tissue
homogeonates (Schmitt et al., 1994) when compared with VI.
PCR is also available for pooled samples of serum or tissue supernatent. Studies have
found PCR capable of detecting BVDV in pools of 50 (Braun et al., 2000) to 100 (Weinstock et
al., 2001) serum samples, although in each case only one pool was examined. A recent study of
100 positive pools found that PCR had a 95% sensitivity on pools of 30 (Smith et al., 2007). In
addition, PCR on pools of 12 to 100 tissue supernatent samples was found to have 100%
sensitivity and 97.4% specificity when compared with ELISA results on individual samples
(Kennedy, 2006).
IHC is possible on various tissues, but is most commonly used on skin biopsies. A recent
study found that IHC had 100% sensitivity for detecting PIs on skin biopsies when compared to
VI, but that it misdiagnosed several TI animals (Cornish et al., 2005). An earlier study had
suggested, with results from a single TI, that IHC would be specific for PIs, for which it had
100% sensitivity when compared to VI (Grooms and Keilen, 2002), but the evidence is weak due
to the lack of variation in samples; sampling only one TI severely limits the external validity of
this study. No other studies in the published literature have evaluated this claim further. With
10
formalin fixed tissues, IHC has shown 98% sensitivity to PI animals dead of mucosal disease and
100% specificity on animals assumed to be negative (Haines et al., 1992).
Difficulties with testing relate to two main issues. First, some PI animals are
seropositive, most often due to maternal antibodies and sometimes due to infection with
heterologous strains, and antibodies may interfere with VI and ELISA tests (Edwards et al.,
1991). This can decrease test sensitivity, and should be taken into account when testing young
calves. Second, variation in viremia in PI cattle has been observed (Brock et al., 1998), which
may lead to decreased sensitivity for PI cattle and again decrease the test sensitivity. Animals
testing BVDV negative after a previous positive test, therefore, cannot be assumed to be
transiently infected. It may be necessary to test animals with dischordant results a third time in
order to increase sensitivity.
It would be desirable to test the fetus of a pregnant import in utero, as fetal prevalence is
higher than adult prevalence and the calf of a pregnant animal is likely to be a greater risk than
the dam. One study has found that the antibody titer of cows carrying a PI fetus may be
significantly higher than that of other pregnant cows (Brownlie et al., 1998), but this may be
misleading in recently infected or vaccinated animals not carrying a PI fetus. In further
inquiries, different cutpoint in an antibody ELISA found sensitivity ranging from 94-100% for
detection of a PI fetus, but specificity only ranged from 39-64% (Lindberg et al., 2001). Another
technique, involving collection and testing of fetal fluids, found that VI was capable of detecting
viremia in a single fetus, but the process may have caused abortion or premature delivery in 14
of 160 cows (Callan et al., 2002). In summary, the available tests for fetal infection are either
nonspecific or possibly dangerous to the fetus. More research in this area would be helpful; at
present, testing of fetal imports must take place after birth.
Vaccination
Prevention of herd BVDV infection after introduction to a herd is dependant on herd
immunity to decrease the spread of infection following contact. Increased herd immunity may
be achieved by vaccination or natural exposure. The use of either modified live (MLV) or killed
vaccines, both of which are commercially available and safe (Stokka and Edwards, 1990;
Castrucci et al., 1991a; Said et al., 1996; Cortese et al., 1997), may be effective at preventing
both viremia with BVDV in heifers using German vaccines, (Frey et al., 2002) and the effects of
11
BVDV in feedlot calves (Cravens, 1991). Efficacy can refer to a number of effects, such as
decreasing viremia and viral shedding or preventing morbidity, although generally refers to
preventing disease. One study found that MLV vaccines prevented all detectable viremia and a
majority of nasal shedding in 28 experimentally infected calves in comparison to 11 control
calves (Dean and Leyh, 1999). Another study detected a decrease in viremia and clinical signs in
15 experimentally infected calves vaccinated with a subunit vaccine compared to 5 controls
(Nobiron et al., 2003). A killed vaccine was found to decrease the duration of viral shedding in 8
calves, although no effect was noted on clinical signs when compared with the 8 control calves
(Peters et al., 2004). It should be noticed that these are all laboratory studies, rather than field
studies, and may not have external validity. One field study, though, in 2581 feedlot calves,
divided between 10 pens on two feedlots, noted that average daily gain was increased and rates
of fever were decreased when a multivalent vaccine with MLV BVD was added to the normal
vaccination scheme, which was used on 2582 calves in 10 pens on the same two feedlots
(Schunicht et al., 2003).
The primary goal of vaccination in herd control programs, however, is preventing fetal
infection; endemic production of PI calves increases the duration and cost of a BVDV outbreak.
MLV vaccines appear to provide good fetal protection, with some level of cross-protection
between strains. Cortese et al. (Cortese et al., 1998a) observed fetal protection in 10 of 12
heifers vaccinated for and exposed to BVDV, but the strain of vaccine and challenge virus were
unrecorded. Two of 25 calves born to dams vaccinated with a BVDV1 vaccine were persistently
infected after BVDV1 challenge (Dean et al., 2003). One study found that 9 of 19 of pregnant
animals experimentally infected were protected from fetal infection with BVDV2 after MLV
vaccination (Brock and Cortese, 2001). A recent study found efficacy of 33%, 37%, and 100%
in groups of 20 heifers exposed to BVDV2, depending on the vaccine protocol used, with the
best protection offered by a combinantion of type 1 and type 2 vaccines (Ficken et al., 2006b).
Another study with similar methods found that all 40 fetuses were protected after vaccination of
the dams with a BVDV-1 vaccine, regardless of the type of the challenge virus (Ficken et al.,
2006a). Similar results were seen with vaccines containing both BVDV types, with 18 of 18
fetuses protected from BVDV1 and 18 of 19 fetuses protected from BVDV2 in one study
(Fairbanks et al., 2004)and 10 of 11 fetuses protected from BVDV1 and 10 of 10 fetuses
protected from BVDV2 in another (Kovacs et al., 2003). Eleven pregnant heifers vaccinated
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with a BVDV-1 virus gave birth to non-PI calves after exposure to PI animals in another study
(Patel et al., 2002), indicating protection from a field-style infection. Killed vaccine was found
to prevent fetal infection in 15 pregnant cows after experimental infection (Brownlie et al.,
1995), though another study observed PI calves from 14 of 24 vaccinated heifers (Zimmer et al.,
2002); in neither study was the type of either the vaccine or the challenge virus provided. In all
the above studies, an appropriate number of control heifers was observed to give birth to PI
calves.
Vaccine duration estimates vary and are based entirely on antibody titers, not viral
challenges, although Ficken et al. (Ficken et al., 2006a) found sufficient fetal protection present
at 370 days post-vaccination. Cows vaccinated with MLV vaccine had antibody titers detected
up to 18 months post-vaccination (Cortese et al., 1998b); the study did not test for antibodies past
18 months. Killed vaccine, however, was noted to produce antibody titers that waned by 12
weeks (Graham et al., 2003). Other cows vaccinated with a killed vaccine in late gestation
produced colostrum that gave calves an 8 week antibody half life (Barringer and Rosenberg,
1995). In calves, it is possible that vaccination at weaning increases the half-life of passive
immunity (Fulton et al., 2004). It is, at the least, apparent that passive immunity does not
interfere with vaccination after 5 weeks of age, as calves receiving BVDV vaccine at 5 weeks of
age showed fewer symptoms of BVD infection, compared to control calves, with or without
colostral protection (Zimmerman et al., 2006).
Vaccination coverage is desired to protect the entire herd from viral transmission.
Adequate protection against BVD outbreaks is thought to occur with a vaccination coverage of
85-99% in dairies (Cherry et al., 1998), but similar calculations, which rely on animal density
and mixing, are unavailable for cow-calf farms. With a lower stocking density, cow-calf farms
may have a lower rate of infectious contacts, but the increased mixing between adults and calves
could increase the number of infectious contacts and, thereby, the necessary level of vaccine
coverage.
Transmission
Observational data on transmission of BVD within cow-calf herds is not available.
Experimental data on transmission suggests that transmission may occur through environmental
contamination. Calves housed in a pen contaminated by the birth of PI calves seroconverted,
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with and without the presence of the dam of the PI calf (Lindberg et al., 2004). Four calves in
the same building as, but with no direct contact with, a PI calf were found to seroconvert, with
maximum distance between pens of 10 meters, which suggests airborne transmission of BVDV
(Niskanen and Lindberg, 2003). The same study found that a pen housing a PI calf was infective
to a susceptible calf entering the day it was vacated, but not 4 days later. However, this work
was carried out in a lab setting, so the application of this to US cow-calf production systems (or
any real-world production setting) is problematic. It is likely that transmission occurs primarily
between PI animals and in-contact susceptible animals, but no studies have defined this
relationship in field situations. Most work on BVDV transmission has been carried out with the
use of computer models.
The dynamics of BVDV transmission have been modeled in a number of ways for dairy
farms. One transmission equation has been suggested by Innocent, I=S(1-(1-)), where I is
infected animals, S is susceptible animals,  is persistently infected animals, and  is the
transmission rate, best represented by R0/(N-1) (Cleveland, 2003). R0, again, is the basic
reproduction ratio and N is the number of animals in the group. This model followed the spread
of BVDV on a dairy farm after introduction of a single PI adult until a steady-state disease
endemicity was reached. The prevalence of PI animals in the herd at the endemic level
resembled field data when  was set to 0.3 per PI per month (Innocent et al., 1997a). When
compared with the results of a mass-action model, the level of agreement validated the
assumptions of the model (Innocent et al., 1997b), but this does not equate with validation using
field data. The results of this model are not likely to be of use on cow-calf farms, due to the
difference in management techniques.
Transmission of BVDV within a cow-calf herd has been modeled using equations
adapted from Innocent et al. (Innocent et al., 1997a) for use in cow-calf herds (Cleveland, 2003).
Seroprevalence and PI prevalence data from three herds were used to validate the model under
field situations of low PI prevalence. The model was most sensitive to the parameter of
infectious contact rate, referred to here as R0. Agreement with field data was highest when R0
was set to 7, as opposed to 3 or 10. With a modeled population of 400, this is equivalent to an 
of 0.0175, compared to 0.0075 or 0.025. This is much lower than Innocent et al. suggested, but
may be appropriate given the lower density of the cow-calf farm in comparison to a dairy. The
transmission rate was chosen based on unpublished serologic field data, and the number of PIs
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present in the herd in the second year after BVDV identification was not significantly different
from that predicted by the model. However, these results were also not significantly different
from those predicted with an R0 of 3 or 10. Thus, the R0 of BVDV in cow-calf herds is likely to
fall between 3 and 10, but further speculation is not possible with this model.
Mathematical models of BVDV in dairy herds also have found that the parameter
representing transmission from PI calves to other groups was the most influential on the size and
impact of an epidemic (Ezanno et al., 2007). This underscores the necessity of defining the
possible range or distribution of R0 for cow-calf herds in order to properly model the disease. R0
values for dairy herds have been suggested to range from 2.3 to 35 (Cherry et al., 1998), with the
lower value indicating transmission from TI animals and the higher representing infectious
contacts for PI animals. The value for PI animals is an estimate and is based on the high-density
dairy herd, and so would not be appropriate for cow-calf models. Cherry et al. set the R0 of 2.3
for TI animals based on unpublished data, but similar models have thrown doubt on the role
played by TI animals in BVDV transmission, and the issue is controversial. One model found
that including transmission by TIs resulted in a similar steady state, arrived at one year earlier
(Innocent et al., 1997a). Another found that increasing the transmission rate for TIs 20-fold did
not significantly change the persistance of herd infection (Viet et al., 2004a). Assuming lifelong
immunity after transient infection, Cleveland found that including infection from TIs would
significantly decrease the clearance time for the herd; (Cleveland, 2003) however, that might
become insignificant if waning immunity was included in the model. If TI transmission is
modeled, however, all of the above studies agree that the R0 for TI animals is much lower than
the R0 for PIs.
The range in estimates of R0, for PIs or TIs, reflects both uncertainity regarding the true
values and variation in the value based on other factors, including management factors and viral
strain, so the effective reproductive rate likely varies between herds. A herd outbreak
investigation by Taylor et al. suggests that transmission rates are affected by management
factors, such as stocking density and maintaining separate groups (Taylor et al., 1994). In that
study one herd with three management groups was followed for 8 months after a BVDV
outbreak, and lower rates of persistent infection were observed in the group with a lower
stocking density and less confinement (Taylor et al., 1994). Viremia levels in infected animals
are one more potential variable in the R0, as higher viremias may cause higher shedding rates.
15
Transiently infected calves in a research setting have shown significantly different viremia levels
with different BVDV strains, so these strains may show different R0 values (Walz et al., 2001).
These natural variations indicate that a range of values would be the best way to model R0, which
could be influenced by a number of issues in the field.
Transmission within a herd is related not only to the rate of transmission from introduced
PIs, but also the rate at which PIs are produced endemically. The endemic PIs will maintain the
infection within the herd by sustaining the infection of susceptible animals after the death of the
imported PIs. The time at which the virus is introduced is key to production of PI calves
(Sprecher et al., 1991; McGowan et al., 1993b; Woodard, 1994). The fetus is only susceptible to
persistent infection between 40 and 125 days gestation (Stokstad and Loken, 2002). In cow-calf
farms, this period spans from early in the breeding season until weaning. Limiting risk factor
exposure during this period curbs production of PI calves within the herd, allowing faster
clearance of infection.
Impact
Infection with BVDV primarily affects calf health and herd reproduction. Persistently
infected animals are assumed to have higher mortality and morbidity than non-PI animals,
although reliable estimates of these rate are not available for calves pre-weaning. Houe found
that PI animals were removed from dairy herds at a higher rate than non-PI animals, but his data
included culling with mortality and only 3 PI calves of <3 months were in the population of the
study (Houe, 1993). A case study of a Saskatchewan cow-calf herd followed calf deaths for one
year and recorded mortality due to presumed persistent infection, but half of the calves dying in
the pre-weaning period were not tested for BVDV (Taylor et al., 1997). A study of PI
prevalence in 133 geographically diverse beef herds found that 10 of 56 calves positive for
BVDV at initial testing died pre-weaning, but no follow-up was used to establish their status as
persistantly or transiently infected and 3 additional calves were lost to follow-up (Wittum et al.,
2001); it may be inferred that a majority were PI, as 33 of 43 retested calves found to be positive.
A comparison of congenitally infected calves (calves with a BVDV antibody titer at birth) and
persistently infected calves with non-infected calves in two dairy herds found an increased
morbidity and mortality rate among infected calves pre-weaning, but did not distinguish between
congenitally infected and PI calves (Munoz-Zanzi et al., 2003). Experimentally produced PI
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calves were all noted to be poor doers in one study, but no normal calves were observed for
comparison and the study was carried out in a laboratory setting limiting external validity
(Stokstad and Loken, 2002). From these studies, it is likely that PI calves will experience higher
morbidity and mortality rates than TI calves. However, due to the low prevalence of PI animals
(see above), it is also likely that the cost of PI morbidity and mortality is outweighed by the cost
of TI morbidity and mortality in calves infected by the PI animals in the herd.
The BVD virus has several effects during transient infection, including
immunosuppression, which is one of the main causes of TI mortality. Immunosuppression
increases both susceptibility to and risk of dying from another pathogen. Haines et al. (2004)
found an increased prevalence of BVDV in calves dying of myocarditis, most associated in this
study with Haemophilus somnus, and pneumonia, associated with Mannheimia hemolytica,
Mycoplasma bovis, and H. somnus, compared to calves dying of non-infectious causes. Infection
status for BVD was established by IHC, so it is uncertain whether the calves were transiently or
persistently infected (Haines et al., 2004). In another study where BVD infection was
established by VI, TI calf mortality was observed to be 11% in two cow-calf herds with a BVDV
outbreak (Campen et al., 2000). An older case report noted a 23% mortality rate in calves during
a BVDV outbreak in an Austrailian herd (Kirkland et al., 1990). However, these three mortality
estimates are based on case reports of limited numbers of farms. There are no published
observational studies or clinical trials of mortality due to transient BVDV infection on a larger
scale.
Morbidity in TI animals is also a significant factor in the cost of BVDV infection in cow-
calf herds. General disease symptoms identified for TI animals include weak calves (Woodard,
1994), diarrhea (Klingenberg et al., 1999), and undifferentiated respiratory disease (O'Connor et
al., 2001). Calf morbidity rates were estimated at 26.7% during a BVDV outbreak in a single
Argentine farm, but the diagnosis of BVD was made based only on necropsy of 6 calves, so the
morbidity rate may be overestimated (Vottero et al., 1992). No other estimates of morbidity
rates are available in the published literature. The specific clinical signs and risk of morbidity
depend in part on the strain involved. Comparing susceptible calves inoculated with two
laboratory-isolated field strains, Bolin et al. (Bolin and Ridpath, 1992) noted an increased
morbidity and mortality with one strain. Castrucci et al. (Castrucci et al., 1991b) also noted an
increase in morbidity and mortality in calves inoculated with cytopathic rather than non-
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cytopathic virus. Kelling et al. compared five different strains isolated from aborted fetuses and
also found that some strains induced more severe symptoms and higher morbidity rates in
experimentally inoculated 6 to 9 month old calves (Kelling et al., 2002).
One of the additional costs associated with BVDV in cow-calf farms comes from the side
effects of morbidity due to BVDV infection. Calves tend to experience a weight gain depression
due to general morbidity. Wittum et al. found that calves with morbidity due to undifferentiated
causes experience, on average, a 15.9 kg decrease in weaning weight (Wittum et al., 1994).
Martin et al. (1999) found that seroconversion to BVDV was associated with lower weight gains
in feedlot calves, and hypothesized this was most likely through its association with respiratory
disease; this could be extrapolated to pre-weaning calves, as the biological basis for the effect
would not be changed by age, although the risk of respiratory disease would.
Morbidity in BVD outbreaks is also due to the potentiation of other pathogens. An
experimental study noted that calves co-infected with BVDV and Mannheimia haemolytica
experienced more severe morbidity than calves infected with only one of the agents or control
calves (Ganheim et al., 2003). Another laboratory study found that simultaneous infection with
BVDV and Infectious Bovine Rhinotracheitis virus (IBRV) produced more severe clinical signs
than infection with IBRV alone (Castrucci et al., 1992). These results suggest some amount of
synergy between the BVDV and other pathogens. In a large study of seroconversion in field
outbreaks, the majority of BVDV seroconversions were associated with other viral infections,
indicating that BVDV may be more of a potentiating factor than a primary disease pathogen
(Graham et al., 1998b). Bjorkman et al. noted a positive association between BVDV and
Neospora caninum serostatus in Swedish dairy cattle experiencing abortions (Bjorkman et al.,
2000). As noted above, a study of feedlot deaths found that BVDV seroconversion was
significantly associated with deaths due to Hemophilus somnus, Mycoplasma bovis, and
Mannheimia hemolytica (Haines et al., 2001). Martin et al. found that seroconversion to BVDV
led to an increase in respiratory disease risk in feedlot calves (Martin et al., 1999), so it is
possible that this effect is present in pre-weaning calves.
Infection with BVDV can affect farm reproduction parameters, including conception rate
and abortion rate. Experimentally, heifers first infected with BVDV within a week of
insemination were found to have significantly lower conception rates than control heifers
(McGowan et al., 1993a). When the study was expanded to field conditions, the same
18
relationship held for heifers, though not for cows (McGowan et al., 1993b). This effect is
notable at the herd level, as well. In one study, four of 8 dairy herds experienced a significant
decrease in conception rate when the oldest PI animal was conceived, which is assumed to be the
time of initial BVDV infection (Houe and Meyling, 1991b). In a study of a single dairy herd
following initial BVDV isolation in a calf, and utilizing historical records from the previous year
for a control, a significantly lower conception rate and a significantly higher proportion of early
abortions and retained placentas was noted (Larsson et al., 1994). Management changes between
the control period and the case period are not reported, but could have been responsible for the
change in the conception rate. In a large cross sectional study, cow-calf herds with PIs present in
the herd had 5% lower pregnancy rates than herds without PIs (Wittum et al., 2001). A large,
multi-year case-control study of the reproductive effects of BVDV in Norwegian dairy herds
found a 3% higher abortion rate in herds with endemic BVDV as determined by antibody levels
in bulk milk samples (Fredriksen et al., 1998). A study of seroprevalence to BVDV and history
of recent abortions in dairy cows found a significantly lower abortion rate in seropositive cows
(Hassig and Lubsen, 1998), but the study did not have data regarding the time of seroconversion,
so only a single sample was taken and seroconversion was not assessed so the seropositive cows
may have been protected from BVDV by immunity from a previous infection.
Conclusion
This literature review identified several knowledge gaps for further research to fill. The
prevalence of PI animals in adult beef cattle is likely low and therefore of little importance, but
this popular belief should be confirmed. The PI prevalence in fetuses and baby calves is also
unknown, however, and is an important parameter for risk calculations. The amount of
morbidity and mortality among PI calves is undefined, as well, and could impact the
transmission of virus within a herd; the uncertainty about the TI morbidity and mortality rates, in
contrast, will have a greater impact on economic analysis of BVDV risk, assuming TIs
outnumber PIs. Transmission dynamics of BVDV on cow-calf farms are currently a matter of
conjecture; while difficult to establish experimentally, model creation and validation may enable
confirmation or refutation of currently held beliefs. The level of risk posed by neighboring
herds, especially from fenceline contact, is also in question. There are some experimental ways
that these could be addressed.
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This literature review, outlines the basic structure of BVDV introduction and spread on
cow-calf farms. The most important source of BVDV infection is contact with PI animals. Good
biosecurity protocols, especially testing, decrease this risk. Importing from tested known
negative herds would decrease the risk posed by imported animals. Vaccination may prevent
spread of virus once introduced and mitigate its impact, which includes reproductive effects in
adults and calf morbidity and mortality. The high cost of BVD necessitates good control and
prevention strategies; a risk analysis model incorporating the identified risks can be a valuable
tool in preparing those strategies.
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CHAPTER 2 - Sensitivity of PCR for detection of bovine viral
diarrhea virus in pooled serum samples and use of pooled PCR to
determine prevalence of bovine viral diarrhea virus in auction
market cattle
Abstract
Two reverse transcription-nested PCR tests, one quantitative (QRT-nPCR) and one
standard (RT-nPCR), were evaluated to assess sensitivity for detection of bovine viral diarrhea
virus of a single positive serum sample in a pool of 30. The RT-nPCR and the QRT-nPCR each
detected 95 of 100 positive pools. There was no observable association of sensitivity with
genotype 1 or 2 for either test. The RT-nPCR was chosen for use in the field prevalence portion
of the study to estimate the prevalence of BVDV in adult beef cows. Serum samples were
obtained from USDA brucellosis testing labs in three Midwestern states. Samples originated
from auction markets and private treaty sales throughout the three states. A total of 2990 serum
samples were collected and ramdomly pooled into 100 pools for testing. The standard RT-nPCR
was applied to pools to determine the prevalence of BVDV in adult cows. Two of the 100 pools
were positive, and each positive pool had a single positive individual sample upon confirmation.
The estimate of apparent BVDV prevalence in adult cows in this study was 0.07%, with a 95%
confidence interval of 0.01% to 0.24%.
Introduction
Bovine viral diarrhea virus (BVDV) is a common disease of US cattle herds (Paisley et
al., 1996). It causes a range of effects, including immunosuppression leading to increased
disease incidence (Kozasaa et al., 2005) and reproductive disorders such as abortion (Fredriksen
et al., 1998), decreased conception rate (Larsson et al., 1994), early embryonic death (McGowan
et al., 1993a), and congenital infections (Munoz-Zanzi et al., 2003). The disease costs producers
and the livestock industry through increased treatment expenses, calf and pregnancy loss, and
decreased weight gain (Larson et al., 2005).
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BVDV is spread primarily through persistently infected animals (PIs) (Houe,
1999). As such, these animals are the most important target of control and biosecurity programs.
Control programs based on herd testing protocols have been predicted to be cost-effective based
on disease models (Stott et al., 2003). In dairy herds, most control programs rely to some extent
on bulk tank milk sampling, which is a low-cost herd screening method (Mars and Van Maanen,
2005), but this is not available for beef herds. Instead, beef herds must rely on samples from
individual animals, such as blood or tissue samples. Testing costs may be decreased by pooling
samples; for calves entering feedlots, limited data indicates that pooling serum samples for PCR
followed by confirmation of individuals in positive pools may be more cost-effective than
individual testing on all samples (Larson et al., 2005).
The advent of polymerase chain reaction (PCR) tests for BVDV has enabled sample
pooling, due to the high analytic sensitivity of PCR. Additionally, PCR tests are not as easily
confounded by antibodies as ELISA and virus isolation tests may be in some circumstances
(Zimmer et al., 2004). These characteristics of PCR testing may make it more effective for
pooling serum samples for testing. However, the cost-effectiveness of any pooling strategy
depends on both the sensitivity of the test and the prevalence of the disease in the population.
While the sensitivity of PCR on pooled sera has not been determined, studies have detected one
positive serum sample in a pool of 50 and 100 samples (Weinstock et al., 2001). Using pooled
supernatants from ear notch samples, Kennedy et al. detected one positive animal among 99
negatives with good sensitivity and specificity (Kennedy et al., 2006). A stochastic model
accounting for dilution effects of pooling calculated that sensitivity would decrease by 6-7% for
pools of 20 compared to individual testing (Munoz-Zanzi et al., 2006), but no laboratory-based
validation of pooled serum PCR sensitivity has been performed.
Knowledge of PI prevalence is also vital to determining the risk posed by importation of
cattle and determining the cost effectiveness of pooling programs. Prevalence of PIs in the US
beef herd is known to some extent for calves (Loneragen et al., 2005), heifers (Cleveland et al.,
2004), and bulls (Gnad et al., 2005). Little data are available on the prevalence in adult cows,
however, one study found no PIs in 1000 non-pregnant adult cattle that were purchased from
multiple operations (White et al., 2007). Wittum et al. traced back the dams of 45 of 56 PI
calves detected in a survey of 19,000 calves and found that 3 were PI (Wittum et al., 2001);
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assuming that PI cows will produce always PI calves (Houe, 1995b) and that test sensitivity is
perfect, adult prevalence could be roughly estimated at 0.02% in those 45 cows.
The purpose of this study is to estimate the sensitivity of PCR for a single BVDV-
positive serum sample in a pool of 30 serum samples and to use the pooled PCR to determine the
prevalence of BVDV infection in adult beef cattle sold through Midwestern auction markets and
private treaty sales.
Materials and Methods
Pooled PCR sensitivity
Samples
Sample size was determined to establish a 95% confidence interval for test
sensitivity with a confidence width of ±5%. One hundred BVDV-positive serum samples were
obtained from diagnostic and research samples from veterinary labs in New York, Kansas, and
Alabama. Samples had previously been diagnosed as BVDV-positive by a variety of tests at the
originating laboratory. The BVDV-negative samples that were incorporated into the pools were
obtained from 782 beef calves that were BVDV-negative by skin biopsy immunohistochemistry,
whole blood virus isolation, and serum virus isolation.
Testing
Two PCR protocols were used throughout the validation phase of the project, a
reverse-transcription-nested PCR (RT-nPCR), and a quantitative RT-nPCR (QRT-nPCR).
Initally all individual positive samples underwent confirmation testing by each of the two PCR
tests in duplicate. The QRT-nPCR established the genotype (BVDV 1 or BVDV 2) of virus in
the sample. For evaluation of test sensitivity to pools, pools were formed with 100 µl of a single
known-BVDV-positive sample and 100 µl each of 29 known-BVDV-negative serum samples.
Pool size was chosen to provide sufficient pool size for economy, based on the presumed
prevalence of BVDV in adult cattle, without excessive dilution. Pools were tested in duplicate
with both the RT-nPCR and the QRT-nPCR.
PCR
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The reverse transcription nested PCR (RT-nPCR) has been previously described in detail
(Givens et al., 2001). Briefly, RNA was isolated from samples using the QIAamp® viral RNA
mini kit (QIAGEN, Valencia, CA, USA) according to the manufacturer’s instructions. All steps
of the RT-nPCR were performed in a single-tube reaction. In the first round, the outer primers,
BVD 100 (5’-GCTAGCCATGCCCTTAG-3’) and HCV 368 (5’-CCATGTGCCATGTACAG-
3’) amplified a 290 base pair sequence of the 5’ untranslated region of the viral genome. In the
second round of the reaction, the inner primers BVD 180 (5’-
CCTGAGTACAGGGDAGTCGTCA-3’) and HCV 368 amplified a 213 base pair sequence
within the first amplicon. After completion of the PCR cycle, 5 µl of the RT-nPCR products
were separated by 1.5% agarose gel electrophoresis. Ethidium bromide staining allowed
visualization of the RT-nPCR using an ultraviolet transilluminator.
In addition, QRT-nPCR was performed to detect BVDV, allowing simultaneous detection
and differentiation of BVDV 1 and BVDV 2. A detailed description of quantitative PCR has
previously been published (DeGraves et al., 2006). Briefly, RNA was isolated from samples as
described above. For the first round of the nested reaction, a Lightcycler® RNA Amplification
Kit HybProbea was used. The outer primers, BVD 180 and HCV 368 amplified a 213 base pair
PCR product from 5 µl of RNA sample. For the second round of the quantitative nPCR a
LightCycler® FastStart DNA Master HybProbe Kita was used. The PCR primers for this reaction
were BVDVL1 (TGCCATGTACAGCAGAGATTT) and BVDVU3
(CATGCCCAAAGCACATCTTA). The hybridization probes used in this reaction were a
BVDVs1dg probe (AYGRAYACAGCCTGATAGGGTGY) labeled on the 3' end with 6-
carboxyfluorescein, a BVDVdg2 probe (CAGAGACCTGCTATTCCGCTAGTAAA) labeled on
the 5' end with Cy5.5 and containing a 3' phosphate to prevent elongation, and a BVDs2 probe
(CAGAGGCCCACTGTATTGCTACTAAA) labeled on the 5' end with an Alexa Fluor 647 and
containing a 3' phosphate to prevent elongation (Studer et al., 2002). After completion of both
rounds in the Lightcycler® instrumenta, data were analyzed and displayed as 670:530 nm
fluorescence ratios for BVDV 1 and 705:530 fluorescence ratios for BVDV 2.
Adult Cow Prevalence
The USDA Brucellosis testing laboratories in 3 Midwestern states provided serum
samples collected from adult cows at auction markets and private treaty sales. Following
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Brucella testing, personnel at Brucellosis testing labs selected and shipped the frozen serum
samples to Kansas State University, where they were cataloged and stored at -80°C. Sample size
was calculated to detect a BVDV prevalence of 0.1% with 95% confidence.
The RT-nPCR test was chosen for use in the field prevalence portion of the study as it is
the standard test and easier to perform. Individual samples were pooled in groups of 27 to 30
and tested for BVDV using RT-nPCR, as described above. Individual samples from positive
pools were tested by serum virus isolation (Givens et al., 2003a) and, if necessary, by RT-nPCR
to identify the number of individual positives.
Data analysis
Sensitivity and prevalence estimates, with confidence intervals were calculated
with the exact methods of proc freq in SASb; measures of association were calculated with proc
genmod in SASb.
Results
Pooled PCR Validation
Individual Samples
Of the individual samples, 60 were BVDV 1 and 36 were BVDV 2 by QRT-nPCR. Of
the four remaining isolates, two were negative by the QRT-nPCR assays and therefore not typed,
and the genotype could not be determined for the other two because the QRT-nPCR was positive
for both type 1 and type 2. The RT-nPCR detected 97/100 individual samples; two false
negatives were BVDV type 1 and one was not typed. The QRT-nPCR detected 98/100
individual samples; the two false negatives were not typed. Only one sample, which was not
typed, was not detected by either the QRT-nPCR or the RT-nPCR. There was no association
observed between BVDV genotype and sensitivity of RT-nPCR (p=0.06) on individual samples.
There was a significant trend for QRT-nPCR not to detect the untyped samples (p<0.05), but no
association between the sensitivity of QRT-nPCR and BVDV 1 (p=0.08) or BVDV 2 (p=0.10).
Pooled Samples
The RT-nPCR detected BVDV in 95/100 pools. Three of the false negatives were
also negative with individual RT-nPCR; the two additional false negatives were BVDV type 2.
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The QRT-nPCR detected 95/100 pools. Two of the false negatives were also negative with
individual QRT-nPCR; two additional false negatives were BVDV 1 and one was BVDV 2.
Four pools were negative by both the RT-nPCR and the QRT-nPCR. There was no association
observed between BVDV genotype and sensitivity of the RT-nPCR (p=0.17) on pooled samples.
There was a small significant trend for non-detection of untyped samples by QRT-nPCR
(p<0.05), but there was no association between QRT-nPCR sensitivity on pools and BVDV
genotype 1 (p=0.06) or 2 (p=0.06).
Sensitivities for individual and pooled samples are shown in Table 2.1. No difference in
sensitivity was detected between the individual tests, between the pooled tests or between the
individual and pooled test protocols (p>0.05 for all associations). As the two tests were
equivalent, the standard RT-nPCR was selected for use in the adult cow prevalence study.
Table 2.1: Sensitivity of tests used to detect BVDV in samples.
Test Sensitivity
Upper 95% Confidence
Interval
Lower 95%
Confidence Interval
RT-nPCR 0.970 0.995 0.916
QRT-nPCR 0.980 0.998 0.930
Pooled RT-nPCR 0.950 0.985 0.887
Pooled QRT-nPCR 0.950 0.985 0.887
Prevalence
Seven pools did not consist of 30 samples because of the breakage and loss of 7 samples
during shipment from one Brucella testing lab to Kansas State University and failure of another
Brucella testing lab to send 3 samples. A total of 2990 serum samples were received from the
three states. From state A, 997 samples were collected; 992 were from auction markets and 5
were from private treaty sales. Seventy-two counties were represented and sale dates were from
January 7 to March 9 2006. Cow ages ranged from 1 to 11 years. Age was not reported on 4
cows and for 2 cows age was reported as 1+. Average of reported ages was 5 years.
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From state B, 1000 samples were collected; 800 were from auction markets and
200 were from private treaty sales. Forty-seven counties were represented and sale dates were
from January 2 to January 31, 2006. Reported ages ranged from 2 to 13 years, with 475 listing
only the categories of adult (114), short and solid (190), broken-mouth (169), or gummer (2) as
ages. Average of reported ages was 5 years.
From state C, 1000 samples were collected from auction market sales, but 7
samples were lost due to broken tubes during shipment, so analysis was performed on 993
samples. Thirty-three counties were represented. Sale dates were not reported but samples were
sent to Kansas State immediately after processing and received on April 6, 2006. Reported ages
ranged from 2 to 10, with 60 cows reported as 1+, 1 cow reported as 2+, and 338 cows reported
as >8 years. Average of reported exact ages was 5.5 years.
Figure 2.1 presents the age distribution of the 2990 samples included by state.
The young category includes all cattle aged 1-3, including those reported as 1+ and 2+, the
middle aged category is all cattle aged 4-7 or listed as short and solid, and the old category is all
cattle aged >8 years or listed as broken-mouth or gummer. Cattle with no reported ages are
categorized as unknown age.
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Figure 2.1: Age distribution of samples by state; young=1-3 years (528 total), middle=4-7
years and "short and solid" (1376 total), old=8 years or older and "gummer" or "broken
mouth" (528 total); all other animals are grouped as unknown (4 total).
Distribution of age groups by state in samples for
prevalence determination
0
200
400
600
800
1000
1200
1400
young middle old unknown
age category
n
u
m
be
r
o
fs
a
m
pl
e
s
re
c
e
iv
e
d
State C
State B
State A
Pools ranged in size from 27 to 30 samples, with a median of 30 samples and seven pools
containing fewer than 30 samples. Two of the 100 pools were positive by RT-nPCR, one
containing 30 samples from state B and one containing 30 samples from state C. One individual
sample in the pool from state C was positive by microtiter virus isolation. In the positive pool
from state B, none of the individual samples were positive by microtiter virus isolation, but one
sample was positive by RT-nPCR. Positive samples from both states were obtained from public
market sales. The positive sample from state B was from a 6-year-old cow, while the positive
sample from state C was from a 5-year-old cow. The estimated prevalence of BVDV in adult
cows was 0.07%, with exact 95% confidence intervals of 0.01% to 0.24%.
Discussion
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This study demonstrated a high sensitivity of two PCR assays (RT-nPCR and QRT-
nPCR) for detection of BVDV in serum samples, both individually and in pools of 30. The
sensitivity of PCR to BVDV in pooled samples reported here relates to a single viremic sample
pooled with 29 BVDV-negative samples. Presumably, the sensitivity would increase with the
number of positive samples in the pool; however, as the test sensitivities are not significantly
different between individual positive samples and positive pools, the increase would most likely
be insignificant as well. Given the low prevalence of BVDV observed in the field study,
however, the likelihood of more than one positive sample in a pool of 30 is low.
This study does not provide any information regarding pooling with larger numbers of
negative samples. The observed decrease in sensitivity related to pooling in this study was less
than predicted by previous modeling (Munoz-Zanzi et al., 2006). This difference could be due to
the use of positive samples that were previously identified as positives in diagnostic labs. In
field samples, sensitivity might be lower due to the greater variation in viremia titer in pre-testing
samples, as opposed to samples previously identified by any diagnostic test.
Pooling of serum has been debated for many tests, as antibody interference could
decrease sensitivity (Zimmer et al., 2004), but antibodies do not interact with PCR on serum.
This study may be considered validation of PCR for detection of BVDV in pools of 30 serum
samples. Although BVDV has been detected in larger pools (Weinstock et al., 2001), the
optimal pool size depends on the prevalence of disease in the population, the sensitivity of the
test at different pool sizes and the cost of the tests used. When prevalence is low, as is the case
with BVDV, larger pools become more cost effective if sensitivity is maintained by decreasing
the total number of tests required. However, the size of the pool must be weighed against the
cost of testing individual samples in positive pools. The cost savings from pooling depend on
the number of positive pools and, as a result, the number of individual samples for which further
testing is necessary. If prevalence is high, a large number of pools may test positive and the cost
of individual testing on positive pools soon becomes prohibitive. At high prevalence, smaller
pools or individual testing are more cost-effective. Larger pools may be used with multiple
poolings, splitting positive pools into smaller pools before individual testing. However, pool size
can be increased to the point of significant dilution, lowering the sensitivity until the number of
false negatives nullifies the cost savings of pooling and the value of testing. Pool size decisions
should therefore be made on the basis of the test sensitivity on pooled samples and the
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prevalence of the disease. With the low prevalence of BVDV noted in this study and others,
smaller pools may be inefficient, while larger pools, if the sensitivity has been validated, could
be most useful especially if any positive pools are split and retested as smaller pools before
individual confirmation. The lowest cost pooling method may be determined more accurately
now, using the calculated sensitivity in pools of 30, and Monte Carlo simulations as previously
published (Munoz-Zanzi et al., 2000).
No associations between BVDV type 1 or 2 and any test’s sensitivity were observed in
this study. However, power was low due to the small number of false negatives with any test.
QRT-nPCR was significantly less likely to detect samples, individually or pooled, for which no
type was known. This is to be expected, however, as the typing in this study was performed by
QRT-nPCR; samples that were negative by all QRT-nPCR tests were not typed.
PCR has been recently validated for use on pooled supernatent from tissue samples
(Kennedy et al., 2006), but in some instances serum samples may be more available or
convenient. In this case we utilized serum samples available in connection with the USDA
Brucella eradication program. Adult cows moving between farms are often purchased and sold
through auction markets. The Midwest region contains a substantial proportion of the beef cows
in the US beef cow herd as well as a large number of auction markets. As cows pass through
auction markets United States Department of Agriculture (USDA) brucellosis eradication
program rules require that a blood sample is collected and tested for Brucella abortus antibodies.
Private treaty sales of cows are also often tested for Brucella abortus. These samples provide a
useful cross-section of the adult cows available for purchase.
No previous studies have provided an estimate of prevalence of BVDV in adult beef
cows in the US. It is often assumed to be 0.1% based on anecdotal evidence and personal opinion
(Munoz-Zanzi et al., 2006; Kennedy, 2006), but no studies have verified that assumption. This
study provides an estimate of the prevalence of BVDV in adult auction market cattle in the
Midwest US. This prevalence estimate is consistent with previous assumptions that adult cattle
are a low-risk source of BVDV introduction to herds, compared with calves and stockers.
Due to the low prevalence of BVDV, this study had insufficient power to detect any
associations between prevalence and age. However, the ages of the two positive samples (5 and
6 years) indicate that some middle-aged cows US auction markets are viremic. This is the age
range that was sampled most heavily overall, but in states A and B more cattle were sampled
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from an older range. The confidence intervals for prevalence in each of the age categories
overlap, so we cannot make a claim for an association between age and prevalence.
The results of PCR testing in this study do not differentiate between persistently infected
(PI) and transiently infected animals. In order to confirm PI status, an animal must be diagnosed
as viremic at more than one time point. The samples used in the sensitivity study were not
guaranteed to be from PI animals, and an inability to follow-up precluded identifying the positive
animals in the prevalence study as PIs. As PI animals carry the greatest risk of BVDV
introduction for a herd (Niskanen et al., 2002b), such follow-up would be very useful in future
studies. In a study of calves entering the feedlot, PCR was performed on pools of 5 to 43 whole
blood buffy coat samples. It was found to be approximately 90% specific to detection of pools
containing PI animals, as opposed to transient infections, when compared with
immunohistochemistry (Larson et al., 2005). Validation of the specificity for PI animals of this
pooled PCR on serum samples, as opposed to transient viremias, would be valuable. Further as
PI animals are persistently viremic and can be detected as positive on any day of their life they
are sampled. Transient infections are viremic for only a short period and so offer fewer viremic
days to be detected making it more likely that any random sample selected if positive is more
likely to be from a PI animal.
The cows sampled for the prevalence estimate do not represent a random sample of all
adult beef cows in the US. They are, however, representative of the population of adult beef
cows available for purchase in the Midwest. Many of the purchased cattle on cow-calf farms in
the Midwest will be sourced from the public market and private treaty sales sampled in this
survey. As the primary interest of this study was to identify the risk of importing an adult PI,
this was an acceptable sampling strategy. The risk for importing adult PIs from these sales may
be higher than the actual prevalence of BVDV in the adult cattle population, as PIs tend to have
low fertility and other health issues and are more likely to be culled. In order to define the risk
posed by animals at these sales, then, this was the most appropriate sampling strategy.
In conclusion, PCR appears to have good sensitivity for detection of BVDV in pooled
serum samples. Prevalence of BVDV in adult beef cattle appears to be very low. This
information should be useful in the design and implementation of biosecurity and control
programs.
a Roche Applied Science, Indianapolis, IN, USA
31
bCopyright (c) 1999 SAS Institute Inc., Cary, NC, USA
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CHAPTER 3 - A stochastic model to assess the risk of introduction
of bovine viral diarrhea virus to cow-calf herds
Abstract
A Monte Carlo model was designed to evaluate the introduction of bovine viral diarrhea
virus (BVDV) to cow-calf farms and the effect of different biosecurity strategies. Risks were
modeled to include imports to the cow-calf herd and stockers imported to adjacent pastures. The
number of persistently infected (PI) animals imported and the probability of BVDV introduction
were monitored for three herd sizes, four import profiles, and six testing strategies. Importing
stockers and importing pregnant heifers were the biggest risk to introduction of BVDV. Testing
stockers decreased the risk they posed, but testing the pregnant heifers was not sufficient to
decrease risk unless their calves were also tested. Test sensitivity was less influential than PI
prevalence on the likelihood of BVDV introduction, even when all imports were tested. This
model predicts the risk of BVDV introduction for individual herd management decisions, and
should prove to be a useful tool for cow-calf producers in controlling the risk of BVDV.
Introduction
Bovine viral diarrhea virus (BVDV) is a common disease of US cattle herds (Houe et al.,
1995b; Paisley et al., 1996; Chase et al., 2003). It causes a range of effects, including
immunosuppression leading to increased disease incidence (Castrucci et al., 1992; Bjorkman et
al., 2000; Kozasaa et al., 2005) and reproductive disorders such as abortion (Fredriksen et al.,
1998), decreased conception rate (Houe and Meyling, 1991a; McGowan et al., 1993a;
McGowan et al., 1993b; Larsson et al., 1994; Wittum et al., 2001), early embryonic death
(McGowan et al., 1993a; McGowan et al., 1993b), and congenital defects (Munoz-Zanzi et al.,
2003; Ellsworth et al., 2006). The disease costs producers and the livestock industry through
increased treatment expenses, calf and pregnancy loss, and decreased weight gain (Wittum et al.,
1994; Gunn et al., 1998; Bennett et al., 1999; Larson et al., 2002).
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Infection of a fetus between 40 and 125 days gestation leads to a persistent infection
(Stokstad and Loken, 2002). Persistently infected animals (PIs) shed virus for life through
oculonasal and other discharges, including feces (Confer et al., 2005) and are generally
considered to be the primary source of BVDV introduction to a herd (Houe, 1999; Niskanen et
al., 2002b).
Biosecurity against BVDV introduction is limited to testing imported animals and
avoiding potentially infectious contact with infected herds. Biosecurity programs based on herd
testing protocols have been predicted to be cost-effective based on disease modeling of Scottish
cow-calf herds (Stott et al., 2003). A variety of antigen tests have been developed to detect
viremic animals, with positive results on samples taken one week apart indicative of a PI.
Testing imported animals may decrease the introduction of BVDV. Avoiding the risk factors of
herd contact on fencelines and communal pastures (Valle et al., 1999) may also decrease risk of
herd infection.
Stochastic models for BVDV spread within farms have been developed and refined for
dairy herds (Innocent et al., 1997a; Innocent et al., 1997b; Cherry et al., 1998; Viet et al., 2004a;
Viet et al., 2004b; Viet et al., 2005; Viet et al., 2006; Ezanno et al., 2007), and one model exists
for spread of BVDV through an endemically infected cow-calf herd (Cleveland, 2003). These
models predict the viral spread and disease impact in currently infected herds, but this does not
provide useful information in regards to biosecurity for uninfected herds. One partial budget
analysis examined the efficacy of testing for BVDV in incoming feedlot calves (Larson et al.,
2005), but management differences make the results inapplicable to cow-calf operations. No
models for introduction of BVDV to a naïve cow-calf herd are available in the literature. The
objective of this study was to develop and apply a stochastic risk analysis model for the
introduction of BVDV to a cow-calf herd.
Model Building
1. Model Structure
The model developed is based on the risk posed to herds by the introduction of
persistently infected animals. Introduction of PIs was modeled to come from two sources:
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imported animals and fenceline contact with imported stockers, (9-12 month old steer and heifer
calves purchased for grazing during the summer). Distributions assigned to the risk level of each
of these three sources can be seen in Table 3.1.
The risk of PI introduction by imported animals is modeled specific to age, purpose, and
reproductive status of the imported animals. Specific classes of imports modeled include
replacement heifers for the breeding herd (either pregnant or open), yearling bulls for use in the
breeding herd, stockers and young calves (1-7 days old for grafting onto lactating cows). The
prevalence distribution for youngstock is applied to bulls, replacement heifers, and stockers.
Typical management practice in US cow-calf herds is to import replacement heifers from a
single herd. Therefore, there is potential for clustering of PIs in heifers according to herd
prevalence. This is modeled by first assigning a binomial value to the BVDV status of the
source herd (based on herd prevalence). The prevalence of heifers in a positive herd is then
modeled as the youngstock prevalence divided by the herd prevalence. Persistently infected
females are unlikely to produce a non-PI calf, so it is assumed that any pregnant import that is a
PI is also carrying a PI fetus (Houe, 1995a). 
Stockers are young weaned calves being grazed for weight gain prior to sale to feedlots,
and are often purchased through an auction market. Stockers, when imported, are typically from
multiple sources and are managed separately from the breeding herd. Thus, the risk posed by
importing stockers is similar to the risk posed by fenceline contact with any infected herd. If PIs
are imported with the stockers, TI’s in the cow-calf herd are modeled to occur through fenceline
contact. The probability that infected stockers sharing a fenceline with the breeding herd will
cause a TI is modeled as a binomial variable.
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Table 3.1: Distributions used in stochastic model
Parameter Description Distribution Source
baby calf and fetal
prevalence
Normal(0.59%,0.08%)
Truncate(0,1)
(Caldow et al., 1993; Wittum et
al., 2001; Cleveland, 2003)
youngstock prevalence Normal(0.47%, 0.11%)
Truncate (0, 1)
(Howard et al., 1990; Taylor et al.,
1995; Fulton et al., 2000;
Cleveland, 2003; Givens et al.,
2003b; Loneragen et al., 2005;
Gnad et al., 2005)
cow prevalence Normal (0.07%, 0.04%)
Truncate (0, 1)
(Smith et al., 2007)
herd prevalence Normal (10.16%, 2.7%)
Truncate (0, 1)
(Wittum et al., 1997; Wittum et
al., 2001)
probability of infection
from fenceline contact
Pert (6%,47%,83%) Expert survey*
test sensitivity Normal (97%, 1.6%)
Truncate (0, 1)
(Frey et al., 1991; Mignon et al.,
1992; Haines et al., 1992; Ellis et
al., 1995; Sandvik and Krogsrud,
1995; Brinkhof et al., 1996; Deregt
and Prins, 1998; Graham et al.,
1998a; Schreiber et al., 1999;
Saliki et al., 2000; Plavsic and
Prodafikas, 2001; Grooms and
Keilen, 2002; Deregt et al., 2002;
Ozkul et al., 2002; Kim and
Dubovi, 2003; Cornish et al., 2005;
Walz et al., 2005; Kuhne et al.,
2005; Kennedy et al., 2006)
*A panel of 5 veterinarians involved in BVDV research.
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The only biosecurity measure included in the model is testing imports for PIs. Options
for testing include the testing of adult imports (bulls and heifers), the testing of calf imports,
which may include the calves of pregnant imports, and the testing of stockers. The number of
PIs detected is based on the number tested and the sensitivity of the test. Test sensitivity is
modeled as one estimate for all diagnostic procedures currently in regular use, derived from a
meta-analysis of test sensitivity (data not shown) which failed to detect a difference in sensitivity
between tests. There was a lack of power in the meta-analysis due to the few published reports
of sensitivity calculations; however, with the data available, the sensitivity distributions are not
significantly different for the different tests. The model assumes that all imports tested are held
in quarantine until test results are obtained, at which point PI animals are removed from the herd.
If calves of pregnant imports are tested, it is assumed that the dams of all positive calves will
also be tested and that pregnant PIs will be preferentially represented in that testing.
The model was programmed with @Risk 4.5.7 (Palisade Corp, Ithaca, NY), an
add-in for Microsoft® Excel 2003 (©1985-2003 Microsoft Corp, Redmond, WA)
2. Sensitivity Analysis
2.1 Materials and Methods
The sensitivity of the model output to the various input distributions was examined based
on a 400 head herd (herds A1-A4 from Table 3.2), with biosecurity strategies M (no testing) and
T (testing all imports) from Table 3.3. All imported heifers were modeled to be pregnant.
Distributions listed in Table 3.1 were fixed one by one at the mean plus 2 standard deviations,
and the mean minus 2 standard deviations to allow examination of the changes observed in
output at the levels that could be expected to occur 95% of the time. Since the herd examined
does not import cows that prevalence distribution was not included in the analysis.
One output was monitored to indicate the introduction of BVDV to the herd after one
year, the likelihood of BVDV introduction (LBI). The LBI is a binomial variable indicating that
PIs were imported and/or TIs were caused by contact with stockers. The mean of LBI, therefore,
indicates the probability of BVDV introduction in any form.
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Table 3.2: Import profile of herds tested
Herd
number of
breeding
females
number of
heifers
imported
number of
bulls imported
number of
calves
imported
number of
stockers
imported
A1 400 60 4 4 100
A2 400 60 4 4 0
A3 400 60 4 0 100
A4 400 60 4 0 0
B1 100 15 1 1 100
B2 100 15 1 1 0
B3 100 15 1 0 100
B4 100 15 1 0 0
C1 50 8 1 every other
year
1 100
C2 50 8 1 every other
year
1 0
C3 50 8 1 every other
year
0 100
C4 50 8 1 every other
year
0 0
Table 3.3: Testing strategies
Strategy Animals tested
M None
O Adult imports (heifers, cows, and bulls)
P Calf imports and calves of pregnant imports
R Stockers imported
S Adult imports, calf imports, and calves of pregnant imports
T All imports (calves, heifers, cows, bulls, calves of pregnant imports, and stockers)
The simulation was run for 3000 iterations at each level with a fixed random number
seed. Distributional effect of each input parameter was calculated by the difference between the
value of each output at the extremes of each parameter distribution.
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2.2 Results
Results of the sensitivity analysis are shown in Table 3.4. When no imports are tested
(strategy M) and stockers are imported (profiles 1 and 3), calf/fetal prevalence and youngstock
(heifer, stocker, and bull) prevalence are equally influential distributions on the likelihood of
introducing BVDV, but calf/fetal prevalence is more influential when stockers are not imported
(profiles 2 and 4) and youngstock prevalence is more influential when all imports are tested
(strategy T). When all imports are tested (strategy T), test sensitivity has the largest effect on
LBI. Changing the probability of an infection from fenceline contact with stockers has the
largest impact of any distribution on LBI when no animals are tested (strategy M). If all animals
are tested (strategy T) and stockers are imported (profiles 1 and 3), the likelihood of infection
from fenceline contact is a more influential distribution than calf/fetal prevalence, but is slightly
less influential than youngstock prevalence.
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Table 3.4: Comparison in the likelihood BVDV is introduced to a 400-head herd in one
year when each input distribution is fixed at the mean minus 2 standard deviations and at
the mean plus 2 standard deviations.
*Profiles A1-A4 from Table 2a: annual imports into the herd
Profile 1 – 60 pregnant heifers, 4 bulls, 4 calves, 100 stockers
Profile 2 – 60 pregnant heifers, 4 bulls, 4 calves
Profile 3 – 60 pregnant heifers, 4 bulls, 100 stockers
Profile 4 – 60 pregnant heifers, 4 bulls
3. Application of the Model
3.1 Materials and Methods
The model was applied to three herd sizes, as shown in Table 3.2, to represent small
medium and large herds Each herd was modeled to include the importation of baby calves,
stockers, both, or neither. Separate simulations were run for each import profile (Table 3.2) to
include pregnant heifers only or non-pregnant heifers only. In addition, each simulation was
repeated with the biosecurity strategies listed in Table 3.3. Import profiles were designed to
Difference in the likelihood BVDV is introduced with change in the input
distributions
All imports are tested (T) No biosecurity strategy (M)
Input
Distribution
Change in
Input
Distribution
Profile
1*
Profile
2*
Profile
3*
Profile
4*
Profile
1*
Profile
2*
Profile
3*
Profile
4*
calf/fetal
prevalence
0.43%-
0.77% 0.011 0.011 0.010 0.010 0.106 0.133 0.101 0.128
youngstock
prevalence
0.25%-
0.69% 0.020 0.011 0.021 0.011 0.103 0.025 0.105 0.025
test
sensitivity
93.8%-
100% -0.043 -0.034 -0.040 -0.032
herd
prevalence
4.66%-
15.56% 0.000 0.000 0.000 0.000 0.048 0.058 0.049 0.060
Fenceline
infection
probability 6%-83% 0.018 0.018 0.179 0.183
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represent average cow-calf herds, in which 15% of animals are replaced annually and all
replacements are purchased as heifers.
Two outputs were monitored for one year for each simulation. First, as in the sensitivity
analysis, was the likelihood of BVDV introduction, LBI. Second, the number of PIs imported
(iPI) was monitored as an indication of the level of risk posed by a specific import profile. The
iPI output includes animals imported to the breeding herd, so imported stockers are not included.
Each simulation included 3000 iterations with a fixed random number seed.
Convergence to less than 5% variation in the mean and standard deviation was observed for all
outputs with less than 3000 iterations. Means were calculated for each of the outputs monitored
by @Risk. The effect of any biosecurity strategy was calculated as the difference between the
output mean for the base herd (no biosecurity strategy) and the strategy in question. Statistical
comparisons were performed using the Student’s t-test.
3.2 Results
The effect of changing biosecurity strategies on LBI is shown in Figure 3.1. The
proportional change in LBI with each strategy was similar across the three herd sizes for each
import profile (with less than 1% difference between herd sizes for any strategy, data not
shown), so the effect was averaged across herd sizes. Briefly, testing calves was more
efficacious than testing adults when pregnant heifers were imported (Figure 3.1a), but not when
non-pregnant heifers were imported (Figure 3.1b). Testing all imports, including stockers, was
always the most efficacious (had the greatest impact on decreasing the likelihood of
introduction) biosecurity strategy when stockers were imported. When imported heifers were
not pregnant, testing stockers alone was more efficacious than testing any other imports (Figure
3.1b, strategy R), but testing the imported calves was more efficacious if the imported heifers
were pregnant (Figure 3.1a, strategy P). Testing adults alone was only effective when no calves,
pregnant heifers, or stockers were imported (Figure 3.1b, strategy O). Importing stockers or
pregnant heifers raised the LBI in all herd sizes and import profiles.
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Figure 3.3.1: Decrease in the likelihood BVDV is introduced to the herd in one year due to
biosecurity strategies, when compared to the base value* for the herd (the mean value if no
testing is done), averaged over herd sizes (400-, 100-, and 50-head).
3.1a) Imported heifers are pregnant
Effect of biosecurity strategies on the likelihood BVDV is introduced
in one year if imported heifers are pregnant
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*base values for likelihood BVDV introduced (LBI) if no testing is used (strategy M):
Herd Size Profile 1 Profile 2 Profile 3 Profile 4
imports Heifers, bulls, calves,
stockers
Heifers, bulls, calves Heifers, bulls, stockers Heifers, bulls
400-head 0.50 0.39 0.49 0.37
100-head 0.29 0.14 0.28 0.13
50-head 0.24 0.08 0.23 0.08
Biosecurity strategies: O (test imported adults), P (test imported calves and calves of pregnant
imports), R (test imported stockers), S (test imported adults, calves, and calves of pregnant
imports), T (test all imports, including calves of pregnant imports)
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3.1 b) Imported heifers are not pregnant
Effect of biosecurity strategies on the likelihood BVDV is introduced
in one year if imported heifers are not pregnant
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*base values for likelihood BVDV introduced (LBI) if no testing is used (strategy M):
Herd Size Profile 1 Profile 2 Profile 3 Profile 4
imports Heifers, bulls, calves,
stockers
Heifers, bulls,
calves
Heifers, bulls,
stockers
Heifers, bulls
400-head 0.28 0.13 0.26 0.11
100-head 0.22 0.07 0.22 0.06
50-head 0.22 0.04 0.21 0.04
Biosecurity strategies: O (test imported adults), P (test imported calves and calves of pregnant
imports), R (test imported stockers), S (test imported adults and calves), T (test all imports)
The effect of changing biosecurity strategies on iPI is shown in Figure 3.2. Since
stockers could not be responsible for PI introduction in the model the proportional change in iPI
with each strategy was similar across the four import profiles for each herd size (with less than
1% difference between import profiles for any strategy, data not shown), so the effect was
averaged across import profiles. Comparing the base values for Figure 3.2a to Figure 3.2b, it is
seen that importing pregnant replacement heifers increases the mean iPI for all herd sizes and
43
import profiles. If imported heifers are pregnant, as in Figure 3.2a, testing imported calves,
including the calves of the pregnant heifers, is the most effective way to decrease iPI. If no
pregnant heifers are imported, as in Figure 3.2b, testing calves has very little effect compared to
testing adults.
Figure 3.2: Decrease in the number of PIs imported in one year, due to biosecurity
strategies, when compared to the base value* for the herd (the mean value if no testing is
done), averaged over import profiles (Table 3.2a).
Effect of biosecurity strategies on the number of PIs imported in one
year if imported heifers are pregnant
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*base values for the number of PIs imported (iPI) if no testing is used (strategy M):
Herd Size Profile 1 Profile 2 Profile 3 Profile 4
imports Heifers, bulls, calves,
stockers
Heifers, bulls,
calves
Heifers, bulls,
stockers
Heifers, bulls
400-head 0.96 0.95 0.94 0.93
100-head 0.23 0.23 0.24 0.22
50-head 0.13 0.13 0.13 0.12
Biosecurity strategies: O (test imported adults), P (test imported calves and calves of pregnant
imports), S (test imported adults, calves, and calves of pregnant imports)
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2 b) Imported heifers are not pregnant
Effect of biosecurity strategies on the number of PIs imported in one
year if imported heifers are not pregnant
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*base values for the number of PIs imported (iPI) if no testing is used (strategy M):
Herd Size Profile 1 Profile 2 Profile 3 Profile 4
Imports Heifers, bulls, calves,
stockers
Heifers, bulls,
calves
Heifers, bulls,
stockers
Heifers, bulls
400-head 0.34 0.34 0.31 0.31
100-head 0.09 0.09 0.08 0.08
50-head 0.05 0.05 0.05 0.05
Biosecurity strategies: O (test imported adults), P (test imported calves), S (test imported adults
and calves)
None of the means for either the LBI or iPI output showed significant differences
between biosecurity strategies or import profiles (data not shown).
Discussion
The model presented here shows that the import profiles of a cow-calf herd impacts both
the risk of introducing BVDV to the herd and the efficacy of any testing strategy.
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Sensitivity analysis to identify the most influential distributions showed that the impact of
a distribution depends on the modeled import profile and biosecurity strategy. The relative
quantity of animals imported from a given age category affected the influence of the prevalence
distribution for that category if imports were not tested (strategy M). For herds not importing
stockers (profiles 2 and 4), calves, including the calves of pregnant heifers, were more
influential, likely due to the higher mean prevalence. When imports were tested, test sensitivity
became the most influential distribution and the probability of infection from fenceline contact
became relatively less important for the herds importing stockers. While the distribution for test
sensitivity is well-defined from the literature, the fenceline infection probability distribution is
broad and based on expert opinion. Therefore, it is reassuring to note that the distribution
representing more uncertainty is not overly influential in the model if distributions in which we
have more confidence are brought to bear.
Importing stockers and allowing fence line contact with the breeding herd increases the
risk of introducing BVDV to a cow-calf herd. Importing stockers may overwhelm the effects of
other, less risky, behaviors, such as importing a small number of baby calves. If both stockers
and pregnant animals are imported, the likelihood of BVDV introduction can be decreased
almost equally by either testing strategies involving stockers alone or by testing the calves of
pregnant imports; the risk from the heifers and their calves is as high as the risk from the
stockers. If imported heifers are not pregnant, however, the risk from stockers is higher than the
risk from other imports and testing stockers is much more efficacious than testing other imports;
relatively more stockers are imported, so there is an arithmetically greater risk from those
animals. In all cases involving imported stockers, however, the best option for decreasing the
risk from stockers is testing the imported stockers. This model assumes that imported stockers
will be housed adjacent to the cow-calf herd. Managing stockers in non-adjacent pastures or
pastures without fence line contact would likely also decrease the risks posed by imported
stockers.
The reproductive status of imported heifers, in the herds examined, greatly impacts both
the risk of introducing BVDV to the cow-calf herd and the number of PIs imported. Pregnant
heifers provide two opportunities for a PI import: the heifer and the fetus. This effectively
doubles the number of imports, with the fetal imports coming from a category with a higher
prevalence. Testing the calves of pregnant heifers has a greater impact on both LBI and iPI than
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testing the heifers, indicating that the majority of the increased risk comes from the fetal imports.
Testing the dams of the PI calves, which the model assumes will occur, adds an additional
benefit.
In 50- and 100-head herds, the impact of fetal imports on the mean LBI is smaller than
the risk posed by importing stockers. This is most likely due to the proportionally higher number
of stockers imported compared to heifers in these herd sizes. Import rates in cow-calf operations
are variable but herds would not ordinarily import more than 15-20% of the herd inventory as
replacement heifers in a given year unless the herd is undergoing significant expansion. Cow-
calf herds may import a substantially larger number of stocker cattle as a routine management
practices or in years where additional grazing resources are available. The larger number of
stockers imported in this model example likely account for the increased risk.
Some cow-calf herds will import a small number of baby calves to raise with their own
calves, typically to graft onto cows or heifers that have lost a calf. The number of these calves is
generally small, and despite their expected higher prevalence of PI-BVDV infection the small
number imported in this model appears to be less of a risk than importing stockers or pregnant
animals. The decision to import calves only increased the number of PI’s imported slightly, but
few calves were imported in the model. The incremental risk associated with importing calves is
the same as that of the feti of pregnant animals, which is higher than any others. However, due
to the small numbers the risk posed by the calves was masked by the risk associated with other
classes of cattle including pregnant heifers and imported stockers. Imported baby calves remain
a risk for disease introduction for numerous pathogens and the relative lack of importance here
should not be interpreted as a lack of any risk.
The choice of testing strategy depends on the import profile of the herd. Herds importing
stockers need to test the stockers to decrease their likelihood of introducing BVDV or alternately
prevent fence line contact with the breeding herd. Herds importing pregnant heifers must test the
calves of those heifers to decrease their risk. Testing calves of imported pregnant heifers, alone
or in combination with testing adults, decreased the risk of introducing BVDV and the number of
imported PIs for any herd in which pregnant heifers were imported. Testing only adult imports
was the most effective strategy for decreasing risk only when no pregnant cattle, calves or
stockers were imported. These results support that if pregnant females are imported, testing the
calves of those imports is necessary for controlling the risk of BVDV. Testing strategies assume
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perfect quarantine of all imports until test results are known; if this is not possible, the model will
be overly optimistic as to the efficacy of testing.
The model simulation results presented here do not examine the risks posed by fenceline
contact or communal pasture with other cow-calf herds, although the risk from fenceline contact
is approximated by the risk from importing stockers. These are both possible risks to a herd, and
should be considered when choosing a full biosecurity strategy.
Due to the difference in management practices between cow-calf herds and feedlots, it is
not possible to directly compare the results of this model with the only previously published
model for BVDV introduction to a beef herd (Larson et al., 2002). However, the findings of that
study indicated that testing individual animals became less cost-effective as prevalence
decreased, which is similar to the findings of the sensitivity analysis here, which showed that
increasing prevalence increased risk to a greater extent when animals were not tested. Results
here indicate that the number of imported PIs decreased more noticeably with a decrease in
youngstock prevalence than with an increase in test sensitivity. The results of Larson et al. may
also be supportive of the findings presented here showing that testing is more effective if it is
carried out in age groups with higher prevalence distributions, such as calves.
This model assumes that test specificity is 100%. While imperfect specificity does not
affect the number of PI animals detected by the test, it does result in a number of non-PI animals
to be culled with the PIs. This will impact a herd through the lost production of the culled
import, as well as through any genetic improvement and production value that animal could have
provided to the herd.
The findings of this model will be useful to cow-calf herds interested in controlling risk
of BVDV importation. It is not feasible for many herds to maintain genetic improvements or
expansion plans with a completely closed herd. Understanding the risks posed by import choices
and the best strategies for counteracting that risk is essential to effective disease control.
Importing stockers has often been advised as grazing management and economic risk-mitigation
strategy, but this model shows that the BVD disease risks associated with stockers can be high.
These risks may be controlled with testing or by preventing fence line contact with the breeding
herd. The model also suggests that importing pregnant heifers is a greater risk to the herd than
non-pregnant heifers, but that this risk can be mitigated by testing the calves of the imported
heifers and culling positives before breeding season. The model has been designed to provide
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output relevant to specific farm situations and should prove to be a useful tool in the decision-
making process for cow-calf operations.
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CHAPTER 4 - A risk-analysis model for the spread of BVDV in
naïve cow-calf herds after introduction
Abstract
A stochastic SIR model was developed to simulate the spread of bovine viral diarrhea
virus (BVDV) through a cow-calf herd and observe the effect of the virus on abortions, early
embryonic deaths, fetal malformations, and calf morbidity and mortality. The model was
examined with three herd sizes (400-, 100-, and 50-head) and four control strategies (no
intervention, vaccination of breeding stock, testing and culling all calves pre-breeding, and both
vaccination of adults and testing of calves). Vaccination and testing combined most decreased
the effects of BVDV and the persistence of the virus in the herd. Testing and culling calves pre-
breeding alone significantly decreased the duration of the outbreak, but was not always more
effective than vaccination alone at decreasing the impact of the virus on the herd.
Introduction
Bovine viral diarrhea virus (BVDV) is a common disease of US cattle herds (Houe et al.,
1995b; Paisley et al., 1996; Chase et al., 2003). Reproductive disorders are often seen, such as
abortion (Fredriksen et al., 1998), decreased conception rate (Houe and Meyling, 1991a;
McGowan et al., 1993a; McGowan et al., 1993b; Larsson et al., 1994; Wittum et al., 2001), early
embryonic death (EED) (McGowan et al., 1993a; McGowan et al., 1993b), and fetal defects
(Munoz-Zanzi et al., 2003; Ellsworth et al., 2006). In addition, BVDV can cause
immunosuppression, which leads to increased disease incidence (Castrucci et al., 1992;
Bjorkman et al., 2000; Kozasaa et al., 2005) The cost to producers and the livestock industry,
from increased treatment expenses, calf and pregnancy loss, and decreased weight gain (Wittum
et al., 1994; Gunn et al., 1998; Bennett et al., 1999; Larson et al., 2002), justifies research on
control measures.
The primary source of BVDV spread in a herd is commonly believed to be
persistently infected animals (PIs) (Houe, 1999; Niskanen et al., 2002b). Fetal infection
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between 40 and 125 days gestation leads to a persistent infection (Stokstad and Loken, 2002)
and they shed virus for life through oculonasal discharge and other secretions (Confer et al.,
2005).
Many models have dealt with the spread of BVDV in dairy herds (Innocent et al., 1997a;
Innocent et al., 1997b; Cherry et al., 1998; Viet et al., 2004a; Viet et al., 2004b; Viet et al., 2005;
Viet et al., 2006; Ezanno et al., 2007), but only one model exists for spread of BVDV through a
cow-calf herd (Cleveland, 2003). Due to management differences between dairy and beef
operations, the latter is the only model in the published literature that is applicable to cow-calf
operations. In particular, the limited breeding season of beef herds limits the risk period for
BVDV infection leading to the birth of PI animals. This allows for targeted control measures,
such as testing and culling calves for viremia before the breeding season. However, it also
increases the risk to the herd at this time period, as a greater proportion of dams will be in the
risk period at one time than on a dairy, when breeding is usually spread out over the course of a
year.
Cleveland designed a stochastic modified Reed-Frost model to determine the
efficacy of removing PI animals from a herd of fixed size and structure. While this model was
quite useful in identifying possible testing strategies for decreasing BVDV infections, it did not
consider either vaccination or the cost-effectiveness of the control strategies. The purpose of this
study was to develop a stochastic model to simulate the spread of BVDV through a cow-calf
herd and the impact of the virus on factors of economic interest, as well as to examine the
efficacy of vaccination and/or testing and culling calves before breeding on decreasing viral
impact.
Model Building
1. Developing the model
A stochastic modified Reed-Frost mass-action model was developed to follow the spread
of BVDV through a cow-calf herd. Variations in the parameters involved in transmission of the
virus, control measures, and sequelae of infection were modeled with the distributions listed in
Table 4.1. Outputs were monitored over a 10-year period, with no intra-year correlations in
distributions. The stochastic model was developed with @Risk 4.5 (Palisade Corp, Newfield,
NY), an add-in for Excel® 2003 (Microsoft Corp, Redmond, WA).
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Table 4.1: Parameter distributions used
Parameter
Description
Distribution Reference(s)
R0 when PIs are
present
Pert (5,7,12) Personal opinion
R0 from fenceline
contact
Pert (1.2,3,5) Personal opinion
Vaccine Efficacy Pert (0.42,0.845,1) (Brownlie et al., 1995; Cortese et al., 1998a;
Patel et al., 2002; Zimmer et al., 2002; Dean et
al., 2003; Kovacs et al., 2003; Fairbanks et al.,
2004; Brock et al., 2006; Ficken et al., 2006a;
Ficken et al., 2006b)
Abortion Rate Pert (1.7%,10%,25%)  (Fredriksen et al., 1998; Hassig and Lubsen,
1998)
TI Mortality Rate
(the percentage of
all TI calves dying
of BVDV in one
year)
Pert (1%,5%,52%) Expert survey*
TI Case Fatality
Rate (the
percentage of
calves morbid
from TI that will
die in one year)
Pert (1%,7%,15%) Expert survey*
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Table 4.1 (cont.)
Parameter Description Distribution Reference(s)
TI Morbidity Rate ( )
( )lityRateTICaseFata
yRateTIMortalit Expert survey*
PI mortality (the percentage
of all PI calves dying of
BVDV before weaning in
one year)
Pert (10%,33%,100%) Expert survey*
PI Case Fatality Rate (the
percentage of PI calves
morbid from BVDV that
will die in one year)
Pert (40%,75%,100%) Expert survey*
PI Morbidity Rate ( )
( )lityRatePICaseFata
yRatePIMortalit Expert survey*
weight lost by morbidity Normal (15.9, 3.5)
Truncate (0, )
(Wittum et al.,
1994)
Vertical transmission risk Normal (81%, 0.7%)
Truncate (0, 1)
(Stokstad and
Loken, 2002)
probability of an EED due
to infection during the risk
period
Normal (16%,8%)
Truncate (0,1)
(McGowan et al.,
1993a; McGowan
et al., 1993b)
probability congenital
defect
Pert (3.2%,13.6%,30%) Expert survey*
Duration of immunity from
transient infection
Binomial(1, 50%) for duration lasting 2
years, all others last 1 year
Personal opinion
*A written survey of 5 veterinarians with field and research experience with BVDV.
The Reed-Frost model, shown schematically in Figure 4.1, follows three interconnected
populations of animals: non-pregnant females, pregnant females, and calves. The number of
animals in each category is calculated every 21 days over the course of the calving and breeding
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season; the model assumes that transient infections occur only when calves are present in the
herd, the period between birth and weaning. The model uses a Markov Chain process to
simulate 10 years within the herd. The herd is assumed to be entirely naïve at the beginning of
year 1.
Figure 4.1: Schematic of the Reed-Frost Model
S: susceptible animals
TI: transiently infected animals
R: resistant animals
PI: persistently infected animals
a: transient infection from contact with a PI
b: loss of immunity
c: immunization through vaccination
d: conception
In any group, transfer of individuals from susceptible to transiently infected (a) occurs
according to the equation:
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where R0 is the reproductive rate, N is the total number of animals in the breeding herd (the sum
of the total number of breeding females and the number of calves born at that time period), and
PI is the number of PI animals present in the herd during that time period.
The transfer from the non-pregnant category to the pregnant category is based on a
standard conception rate for the length of the herd breeding season (either 60 or 100 days).
Infections in pregnant animals are followed in cohorts based on the time period of their
conception, allowing calculation of the number of infections during risk periods for EEDs and
PIs.
On an annual basis, the number of dams immunized by vaccination is calculated and
added to the resistant category, accounting for vaccine efficacy. The number of susceptible dams
at the beginning of the year is the difference between the total number of breeding females and
the number of resistant dams. The number of susceptible calves added to the herd in each 21 day
time period is based on the number of susceptible dams expected to have calved in that period,
based on their conception cohort from the previous year. Similarly, the number of PI calves
added to the herd in each 21 day calving period is based on the number of dams that were
modeled to have produced a PI calf, according to time of conception in the previous breeding
season. Persistently infected calves of imported animals were added to the herd randomly
throughout the calving period.
The number of resistant cows and calves in any given time period is the sum of the
number of immunized animals (if vaccine is given) and the number of animals in that age
category previously infected. Immunity from a natural infection lasts at least 12 months in the
model, with a binomial process to model the persistence of immunity for a further 12 months in,
on average, half the animals. Immunity from vaccinination is assumed to last only 12 months,
with the annual number of effectively immunized animals based on the number vaccinated and
the vaccine efficacy based on available published estimates of efficacy in preventing PI in cows.
2. Sensitivity Analysis
2.1 Materials and Methods
The sensitivity of the model output to the various input distributions was examined based
on a 400-head herd to which one PI calf was introduced in year 1. The analysis was performed
with each of the four control strategies considered: doing nothing, testing of every calf in the
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herd and culling PI calves pre-breeding , vaccination of all breeding animals, and both
vaccinating breeding animals and testing and culling calves pre-breeding. To allow examination
of the changes observed in output at the levels that could be expected to occur 95% of the time,
normal distributions listed in Table 4.1 were fixed one by one at the mean plus 2 standard
deviations and the mean minus 2 standard deviations. In the case of triangular distributions, the
minimum and maximum were used as upper and lower values. The effect of the changing
distributions was measured as the change in the mean number of endemic PIs, that is, the number
of PI calves born due to infections in the herd after 10 years, a measure of the spread of infection
in the herd. The difference between the mean number of endemic PIs at the extremes of the
distribution was calculated. Each simulation was run with 3000 iterations and a fixed random
number seed.
2.2 Results
The results of the sensitivity analysis are shown in Table 4.2. Distributions listed in
Table 4.1 that had no direct link to the number of endemic PIs (TI mortality rate, TI and PI case
fatality rate, abortion rate, EED rate, and the amount of weight lost due to morbidity) were not
included in the analysis. When no control program was in place, PI mortality rate was the most
influential distribution. When vaccination was used for control, alone or in combination with
testing, vaccine efficacy was the most influential. When testing and culling calves before
breeding was the only control strategy, test sensitivity was the most influential. R0 was one of
the most influential distributions in every scenario.
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Table 4.2: Comparison in the number of PIs born in a 400-head herd in ten years when
each input distribution is fixed at the mean minus 2 standard deviations and at the mean
plus 2 standard deviations (normal distributions) or at the minimum and maximum values
(pert distributions).
Difference in the number of PIs born in a herd in 10 years with
change in the input distributions
Input
Distribution
Change in
Input
Distribution No control Vaccination
Test-and-cull
calves pre-
breeding
Vaccination and
test-and-cull
calves pre-
breeding
R0 5-12 -51.47 11.26 0.22 0.05
Vaccine
Efficacy 42%-100% 0 -75.74 0 -0.12
PI mortality
rate 10%-100% -76.79 -24.23 -0.22 -0.03
Vertical
transmission
rate 79.6%-82.4% 1.60 0.62 0.01 0.0003
Test
Sensitivity 93.8%-100% 0 0 -0.65 -0.06
3. Model Application
3.1 Materials and Methods
To assess the performance of the model, simulations were run for three herds, with 50,
100, and 400 head. Virus was introduced to each herd as a single PI calf imported in year one,
after which the herd was assumed to be closed in order to determine the impact of a single
introduction. Each herd was simulated once for each of the control options built into the model:
no control program, vaccination, testing and culling calves pre-breeding, and vaccination and
testing and culling calves pre-breeding. A herd with no control program, with no interventions
taken, was used to calculate the base value. Vaccination indicates vaccinating all breeding
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females. Testing and culling calves pre-breeding denotes testing all calves in the herd and
removing any PIs detected before the beginning of the breeding season. The results of these
simulations were collected for the numbers of endemic PIs, abortions, calf morbidities, and calf
mortalities for 10 years after BVDV introduction. In addition, the annual probability of the
presence of at least one PI in the herd was monitored to enable the calculation of clearance rates.
Each simulation was run with 3000 iterations and a fixed random number seed. Means,
percentiles, and standard deviations were calculated automatically in @Risk. 95% confidence
intervals around the means were calculated with the Student’s t distribution. 95% confidence
intervals around the percentiles were calculated with the normal Z distribution.
3.2 Results
Convergence was observed in fewer than 3000 iterations for all simulations, measured as
less than a 5% change in output mean, standard deviation, and every 5th percentile.
None of the means for any output parameters (endemic PIs, abortions, calf morbidity, or
calf mortality) are significantly different between any control programs for any herd size (data
not shown). The percentiles of certain values, however, are significantly different based on
comparison of 95% confidence intervals, as is shown in Figures 4.2 through 4.5. First-order
dominance was observed for all output parameters with a combination of testing and culling
calves pre-breeding and vaccinating breeding animals. The survival curves for BVDV in the
herd are shown in Figure 4.6. No significant advantage is observed for adding vaccination of
adult animals to testing and culling of calves pre-breeding.
Discussion
The strength of this model is its flexibility, its ability to be adapted to different herd sizes
and management procedures. However, some general lessons can be drawn from the results of
the model at this point.
The relative importance of the distributions in the model, as seen in the sensitivity
analysis, provides useful insight regarding the impact of different control measures. An increase
in R0 from the minimum to the maximum value decreases the number of endemic PIs when no
control program is in place, but the opposite is true if there is some form of control program
used. This would imply that, if natural infection is allowed to occur, a highly infectious strain
would move through the herd quickly, giving natural immunity to dams before they are at risk
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for producing a PI fetus. The high impact of changing vaccine efficacy from its 5th to its 95th
percentile is due in part to the width of its distribution; compared to the vertical transmission
rate, the variation is more extreme and would be expected to produce a bigger effect. This wide
distribution is meant to capture the natural variability of vaccine efficacy, which depends on the
strain of viral challenge, the vaccine used, and several management factors. The PI mortality
rate and R0 distributions are also wide in order to account for similar natural variability, as well
as uncertainty, so their influential behavior is expected.
Increasing PI mortality rate decreases the number of PIs born to the herd. As PI mortality
is calculated by the model every three weeks, a high mortality rate results in PIs being removed
from the herd quickly, before any or all new fetuses have reached the risk period for persistent
infection. This model, then, supports anecdotal evidence that BVDV outbreaks are less severe if
PI calves die young.
There are no significant differences in the means of any output measures under any of the
control strategies. This is understandable, as the variability and uncertainty in the model allow
for a wide range of results, which is realistic when compared to field experience of BVDV
outbreaks. The tails of the output distributions, however, are significantly different based on
comparison of probabilities, implying that control programs will decrease risks, and specifically
decrease the risk of large effects. This underscores the importance of using stochastic models to
determine disease risk; a deterministic model would lose the distinction between control
strategies. This is especially important when uncertainty and/or natural variability is important
to an input parameter. For example, both vaccine efficacy and the R0 of BVDV are reliant on
outside factors that vary considerably between herds, such as nutrition, stocking density, strain of
the infecting virus (virulence and similarity to the vaccine strain) and other management factors.
As seen in the sensitivity analysis, both of these distributions are highly influential on the output
of the model. Using stochastic methods to account for the variability involved allows for a more
sensitive model, able to predict the range of expected outcomes from BVDV introduction.
Figure 4.2 Cumulative distributions for the number of abortions observed in 10 years after
BVDV introduction in a (a) 400-head herd, (b) 100-head herd, and (c) 50-head herd.
Key:
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2(b)
Cumulative risk of Abortions in a 100-head herd after BVDV
introduction
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2(c)
Cumulative risk of Abortions in a 50-head herd after BVDV
introduction
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The results presented here indicate that testing all calves in the herd and culling PI calves
pre-breeding greatly decreases the risk of the outputs examined. In 400- and 100-head herds,
abortion risk is decreased more by test-and-cull strategies than by vaccination alone (Figure 4.2).
In 50-head herds, however, there is mixed dominance between vaccination alone and testing and
culling calves alone; vaccination significantly decreases risk of low levels of abortions, but
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testing and culling calves pre-breeding is more effective at preventing larger abortion storms.
Combining both testing and vaccination shows first-order dominance for all herd sizes, as would
be expected. The effect of herd size is most likely related to the smaller pool of susceptible
animals for infection and the smaller number of PIs in 50-head herds. Vaccination would lower
the effective R0 (RE) below the level necessary to maintain an infection in most cases, but in
some situations, in which vaccine efficacy was low or R0 was high, herd immunity would fail
and it would be necessary to remove the source of the infection, the PI calves. In small herds,
the probability of all PI calves dying without removal is higher because there are fewer PIs to
begin with, usually only one or two; in larger herds, it is more likely that one of the many PIs
will survive the high mortality rate to infect more animals and would need to be removed with a
test-and-cull program.
Figure 4.3: Cumulative distributions for the number of morbidities observed in 10 years
after BVDV introduction in a (a) 400-head herd, (b) 100-head herd, and (c) 50-head herd.
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Cumulative risk of Morbidity in a 100-head herd after BVDV
introduction
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 2 4 6 8 10 12 14 16 18 20 22 24
Number of sick calves
Pr
o
ba
bi
lit
y
o
fe
xc
ee
di
n
g
x
-
ax
is
va
lu
e
3(c)
Cumulative risk of Morbidity in a 50-head herd after BVDV
introduction
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In contrast to abortions, the risk of calf morbidity and mortality (Figures 4.3 and 4.4) is
usually decreased more by the vaccination of breeding animals than by the test-and-cull strategy
alone, although testing is a significant improvement over doing nothing. In 400-head herds,
vaccination alone and test-and-cull alone decrease the risk of mortality equally (Figure 4a). The
model counts morbidity and mortality during the calving season, before endemic PIs would be
detected by testing and culled, thereby allowing the PIs to produce TI-associated morbidity and
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mortality. Vaccination, however, can decrease morbidity and mortality in calves through the
passive immunity conferred by vaccinated dams, which protects the calves from infection before
the breeding season starts and PI calves would be culled. An alternative to this could be to test
and remove PI calves at birth, but this model does not address that option as testing and culling
calves is more commonly performed at branding, just prior to the breeding season. In 400-head
herds, vaccination may not be as effective as in the smaller herds because of the larger pool of
susceptible animals. These animals can maintain an infection by supplying new PIs to infect
subsequent calf crops, which is less likely when only one or two animals remains susceptible
every year compared to 8 to 10.
Figure 4.4: Cumulative distributions for the number of mortalities observed in 10 years
after BVDV introduction in a (a) 400-head herd, (b) 100-head herd, and (c) 50-head herd.
Key:
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4(b)
Cumulative risk of Mortality in a 100-head herd after BVDV
introduction
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4(c)
Cumulative risk of Mortality in a 50-head herd after BVDV introduction
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 1 2 3 4 5 6 7 8 9 10 11 12
Number of dead calves
Pr
o
ba
bi
lit
y
o
fe
xc
ee
di
n
g
x-
ax
is
v
al
u
e
In the case of endemic PIs (Figure 5), there is no significant decrease, based on
comparison of 95% confidence intervals, in the cumulative probability distribution of endemic
PIs when vaccination is added to a test-and-cull strategy for calves compared to a test and cull
strategy alone. Vaccination alone does significantly decrease risks compared to no control, but
has significantly higher risks than a calf test and cull strategy alone. This effect appears to be
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consistent across herd sizes. This strategy, of course, has calves tested and removed from the
herd before they can expose gestating cows in the PI risk period (40 to 125 days gestation). A
sensitive testing strategy for removal to prevent exposure and infections is more effective than a
vaccination program subject to variable efficacy.
Figure 4.5: Cumulative distributions for the number of endemic PIs observed in 10 years
after BVDV introduction in a (a) 400-head herd, (b) 100-head herd, and (c) 50-head herd.
Key:
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5(b)
Cumulative risk of endemic PIs in a 100-head herd after BVDV
introduction
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5(c)
Cumulative risk of endemic PIs in a 50-head herd after BVDV
introduction
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Of interest to producers is how long an outbreak might last, once BVDV is introduced to
their herd. The survival curves in Figure 4.6 indicate that testing and culling calves pre-breeding
significantly decreases the probability of an outbreak of long duration. By removing PIs from
the herd before the conception and infection of new fetuses, the herd is able to clear the virus
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more quickly. As suggested by the results discussed above, test-and-cull methods were able to
decrease the number of PIs present in the herd, the source of infection by BVDV.
Figure 4.6: Persistence of PIs in herd 10 years after BVDV introduction in a (a) 400-head
herd, (b) 100-head herd, and (c) 50-head herd.
Key:
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6(b)
Persistance of PIs in a 100-head herd after introduction
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6(c)
Persistance of PIs in a 50-head herd after introduction
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In the current model, vaccination alone does decrease the probability of a longer outbreak
when compared to no control program. The addition of vaccination to a pre-breeding test and
cull of calves does not significantly decrease the probability of a longer outbreak compared to
testing and culling calves alone, however. This model does not consider the possible
transmission of virus by transiently infected animals, which would likely decrease the impact of
testing and increase the value of vaccination.
Herd size has an effect on the duration of outbreaks. In the 400 head herd some
probability of at least one PI remaining in the herd persists through 10 years is unless a test-and-
cull strategy is utilized; in 50- and 100-head herds, self-clearance of BVDV infection was always
observed within 8 and 10 years of introduction, respectively. This is, again, likely a result of the
number of susceptible animals available in the herd for maintenance of infections. In a 50- or
100-head herd, it is possible for RE to be lowered sufficiently by natural herd immunity,
following infection, for self-clearance. 400-head herds are likely to have clusters of infections,
maintaining clusters of susceptible animals that can be infected in following years, because the
larger number of animals precludes complete mixing every year. This allows for maintenance of
a rotating susceptible population of dams that can provide new PI calves to the herd each year.
In addition, the total number of PIs in a 400-head herd is larger, so the probability that at least
one will survive to infect a dam during the risk period is greater than in a 50-head herd, which
may only have a single PI at a time. If one PI dies before breeding begins in a 50- or 100-head
herd, there is a good probability that the infection is cleared in that year. However, if a single PI
dies before the risk period in a 400-head herd, there is a good probability that there are other PIs
to maintain the infection.
The model predicts that vaccination will significantly increase the probability of early
clearance compared to doing nothing, but it does not alter the maximum predicted length of an
outbreak. In a 400-head herd that does not test calves, RE is not lowered to the point of always
clearing BVDV from the herd within 10 years, though the probability of clearing the infection
from the herd gradually increases. A herd of this size would have a supply of susceptible
animals to maintain the infection if PIs remain in the herd during the risk period, even with
vaccination, as vaccine efficacy is not always sufficient to create herd immunity. Also, as noted
above, the larger number of PI calves maintains infection pressure, despite a high mortality rate,
if a test-and-cull program is not implemented. These results are useful for decision making at the
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herd management level, as they indicate that vaccination is not as effective in decreasing the
length of an outbreak in 400-head herds as testing and culling calves pre-breeding, which is
always an effective measure to ensure clearance of BVDV.
The model presented here does not take into account a constant source of infection; it is
assumed that the herd is completely closed for 10 years following introduction. The
effectiveness of the different control strategies might be changed by a constant source of BVDV
introduction. The repeated importation of PIs would change clearance rates, but that could be
controlled to some extent by testing imports. In the presence of other herds on shared fencelines
or communal pasture, however, removing the source of the infection is not possible. In that
situation, it may be necessary to vaccinate in order to control risk.
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CHAPTER 5 - Economic risk analysis model for bovine viral
diarrhea virus biosecurity in cow-calf herds
Abstract
A stochastic model was designed to calculate the cost-effectiveness of biosecurity
strategies for Bovine Viral Diarrhea Virus (BVDV) in cow-calf herds. Possible sources of
introduction considered were imported animals, including the calves of pregnant imports, and
fenceline contact with infected herds, including stocker cattle raised in adjacent pasture. Spread
of BVDV through the herd was modeled with a stochastic SIR model. Financial consequences
of BVDV, including lost income, treatment costs, and the cost of biosecurity strategies, were
calculated for 10 years, based on the risks of an open herd with a user-defined import profile.
Results indicate that importing pregnant animals and stockers increase the financial risk of
BVDV. Strategic testing is the most cost-effective biosecurity option when stockers are not
imported; in most cases, vaccination in combination with testing is a co-dominant strategy for
lowest risk to herds that import stockers. The choice of a biosecurity strategy is specific to the
risks of any particular herd.
Introduction
Bovine viral diarrhea virus (BVDV) costs the beef industry through decreased production
and increased expenses (Wittum et al., 1994; Gunn et al., 1998; Bennett et al., 1999; Larson et
al., 2002). It is a common disease in the US cattle herd (Houe et al., 1995b; Paisley et al., 1996;
Chase et al., 2003).
Fetal infection between 40 and 125 days gestation leads to a persistently infected animal
(PI) (Stokstad and Loken, 2002), which will shed virus for life through oculonasal discharges
(Confer et al., 2005). Persistently infected animals are generally considered to be the primary
source of BVDV introduction to a herd (Houe, 1999; Niskanen et al., 2002b).
Animals with transient infections (TIs), or infections of animals not in the risk period to
become PI, experience a range of effects. In adults, these are mostly reproductive disorders such
as abortion (Fredriksen et al., 1998), decreased conception rate (Houe and Meyling, 1991a;
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McGowan et al., 1993a; McGowan et al., 1993b; Larsson et al., 1994; Wittum et al., 2001), early
embryonic death (EED) (McGowan et al., 1993a; McGowan et al., 1993b), and congenital
defects (Munoz-Zanzi et al., 2003; Ellsworth et al., 2006). In calves, common symptoms
include immunosuppression leading to increased overall disease incidence (Castrucci et al.,
1992; Bjorkman et al., 2000; Kozasaa et al., 2005).
Biosecurity against BVDV introduction includes testing imported animals and avoiding
potentially infectious contact with infected herds, especially PI animals, as well as vaccination
and test-and-cull programs. Testing strategies on imported animals aim to reduce the number of
PIs introduced to a herd. Disease modeling of biosecurity programs based on herd testing
protocols indicates that they may be cost-effectiveness (Stott et al., 2003). Vaccination is meant
to decrease the spread of the virus once it is introduced to the herd; primarily, it is meant to
prevent the birth of new PIs. Test-and-cull programs, often focusing on calves, are used to
decrease the number of PIs present in the herd. This is commonly done before the breeding
season, so as to decrease the number of sources of infection present during the risk period for
producing more PIs. In addition to these strategies, avoiding the risk factors of herd contact on
fencelines and communal pastures (Valle et al., 1999) also may prevent herd infection.
There are a multitude of stochastic models to study the effects of BVDV control
programs on dairy herds (Innocent et al., 1997a; Innocent et al., 1997b; Cherry et al., 1998; Viet
et al., 2004a; Viet et al., 2004b; Viet et al., 2005; Viet et al., 2006; Ezanno et al., 2007).
Management differences between dairy and beef operations however, make those models less
helpful in decision making for cow-calf producers. In particular, the limited breeding season of
beef herds limits the risk period for BVDV infection leading to the birth of PI animals. This
limited breeding season also increases the risk to the herd during this time period, as a greater
proportion of dams will be in the risk period at one time than on a dairy, when breeding is
usually spread out over the course of a year. Also, testing strategies in dairy herds often include
monitoring of the bulk milk tank, which is not possible in beef herds. In addition, the spread of
the virus is affected by the lower animal density of pastured beef herds compared to intensively
managed dairies and by the continued contact between calves and adults until weaning in beef
herds.
One model has been developed for BVDV in a cow-calf herd (Cleveland, 2003). This
model was designed to examine the effect of test-and-cull strategies in an endemically infected
73
cow-calf herd. While this model is quite useful for the closed, infected herd looking to control
the infection, it does not address the effectiveness of biosecurity strategies in herds not currently
infected. It also does not provide estimates of cost-effectiveness, the level at which producers
need to make decisions. One partial budget analysis examined the efficacy of testing for BVDV
in incoming feedlot calves (Larson et al., 2005), but management factors again make the results
less applicable to cow-calf operations. No models are available in the literature that address the
overall impact of BVDV within cow-calf herds. The purpose of this study was to develop a
stochastic risk-analysis model for the introduction, spread, cost, and control of BVDV in cow-
calf herds.
Model
This paper describes the integration of three Monte Carlo simulation models: a model for
the annual introduction risk for BVDV to a cow-calf herd and the impact of biosecurity
strategies, a model for the effects of BVDV for 10 years after introduction to a naïve cow-calf
herd and the impact of control strategies, and a model for the economic costs of BVDV effects,
biosecurity, and control for 10 years. The first two models have been described in previous
chapters.
Briefly, the introduction model is a Monte Carlo model in which the probability of
introducing BVDV to a herd in any year is calculated based on two risk categories, imports and
fenceline contact. The number of PIs imported to the herd is based on the number of animals
imported of a given age category and/or pregnancy status, the PI prevalence in that age group,
including fetal prevalence for calves of pregnant imports, and the testing strategy to prevent PI
importation. In addition, the probability of infection through contact with other herds through
fenceline contact is modeled based in part on the prevalence of BVDV-infected herds, leading to
a binomial variable for infection from fenceline contact. Fenceline infection can also be due to
contact with imported stockers, or young animals grazed on available pasture for sale to feedlots
or finishers. These values (number of infected PIs, fenceline infection, and communal pasture
infection) are calculated independently for 10 years based on the import profile and management
of the herd.
The model for the spread and effects of BVDV is driven by the introduction of the virus
via the introduction model. Persistently infected animals are modeled to join the herd at the
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beginning of the calving season in the year in which they are introduced. Infection in the herd is
tracked by means of a modified Reed-Frost model based on the number of animals in the herd,
the number of PIs in the herd, and the number of susceptible animals. This calculation is based
on 3-week periods, for which conception is also modeled, allowing calculation of infections
during the risk period for fetal persistent infection. The occurrence of fenceline infection is
modeled as a binomial distribution based on prevalence of positive herds and estimated
likelihood of transmission given a positive herd. When infection occurs by fenceline contact a
single PI is added to the Reed-Frost calculation for a single 3-week time period.
The current model integrates both the presence of PIs from outside introduction and from
endemic infections. In each year, the number of PIs produced in the previous year’s breeding
season are added to the herd during the corresponding 3-week period in the calving season.
Persistently infected calves may be removed from the herd each year by a pre-breeding test-and-
cull strategy.
The effects of BVDV were modeled primarily on an annual basis, based on the number of
infections in each risk group. The number of abortions was based on the number of infected
females on an annual basis, while the number of TI morbidities and mortalities were based on the
number of infected calves on an annual basis. The number of PI mortalities was calculated for
each 3-week period, allowing the PIs to be removed from the herd at death. The number of PI
morbidities, however, was based on the number of PIs present on an annual basis, as the
morbidities do not impact the risk to the herd. The number of EEDs and congenital defects,
however, were calculated based on the number of infections during their respective risk periods,
as are the number of PIs to be born. EEDs occuring before the end of the breeding season, at
which time the dams are allowed to rebreed, were distinguished from EEDs occuring after the
breeding season has ended and rebreeding was no longer possible.
Vaccination was modeled for breeding females on an annual basis, removing a number
from the susceptible category for a single year based on vaccine efficacy. Vaccinated or
otherwise immune animals give birth to immune calves. Immune calves remain so until
weaning.
The economic model for the total 10-year cost of BVDV in cow-calf herds was based on
a partial budget, integrating the costs of management and lost income. Parameters used in this
model are shown in Table 5.1. Annual inputs from the introduction risk and herd spread models
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were used to calculate the cost of BVDV for that year. Cost was based on both treatment cost,
based on the number of calf morbidities, and lost income. Lost income was based on the price
per pound, which was modeled on a 10-year draw of historical prices for the month of weaning,
of the weight of animals not available for sale because of BVDV effects. Total lost income was
calculated as the price per pound times the lost animal weight. The lost animal weight was the
sum of the decrease in weaning weight in morbid calves and the total weight of calves lost to
BVDV mortality. Decreased weaning weight was the difference in weaning weight from the
average in calves that wean at a decreased weight because of BVDV. The decreased weaning
weight of calves due to morbidity was modeled based on the number of morbid calves.
Decreased weaning weights were also calculated for calves based on the number of EEDs
occuring in cows that successfully rebred before the end of the breeding season. Calf mortality
was modeled based on the number of abortions, EEDs occuring to cows that fail to rebreed,
congenital defects, TI mortality, and PI mortality. The possible weaning weight of lost calves
was based on a binomial calculation for the numbers of heifers and steers that were lost and on
the weaning weight distribution for each gender.
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Table 5.1: Distributions used in economic analysis of biosecurity schemes
Parameter
Description
Distribution Reference(s)
Baby calf and fetal
prevalence
Normal(0.59%,0.08%),
Truncate(0,1)
(Caldow et al., 1993; Wittum et al., 2001;
Cleveland, 2003)
Youngstock
prevalence (stockers,
bulls)
Normal(0.47%, 0.11%)
Truncate (0, 1)
(Howard et al., 1990; Taylor et al., 1995;
Fulton et al., 2000; Cleveland, 2003; Givens et
al., 2003b; Loneragen et al., 2005; Gnad et al.,
2005)
Heifer prevalence If source herd is positive (from
a binomial based on herd
prevalence), youngstock
prevalence/herd prevalence
Expert survey
Cow prevalence Normal (0.07%, 0.04%)
Truncate (0, 1)
(Smith et al., 2007)
Herd prevalence Normal (10.16%, 2.7%)
Truncate (0, 1)
(Wittum et al., 1997; Wittum et al., 2001)
Probability of
fenceline infection
Pert (6%,47%,83%) Expert survey
R0 for PIs Pert (5,7,12) Personal opinion
R0 from fenceline
contact
Pert (1.2,3,5) Personal opinion
Test sensitivity Normal (97%, 1.6%)
Truncate (0, 1)
(Frey et al., 1991; Mignon et al., 1992; Haines
et al., 1992; Ellis et al., 1995; Sandvik and
Krogsrud, 1995; Brinkhof et al., 1996; Deregt
and Prins, 1998; Graham et al., 1998a;
Schreiber et al., 1999; Saliki et al., 2000;
Plavsic and Prodafikas, 2001; Grooms and
Keilen, 2002; Deregt et al., 2002; Ozkul et al.,
2002; Kim and Dubovi, 2003; Cornish et al.,
2005; Walz et al., 2005; Kuhne et al., 2005;
Kennedy et al., 2006)
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Table 5.1 (cont.)
Parameter Description Distribution Reference(s)
Abortion Rate Pert (1.7%,10%,25%)  (Fredriksen et
al., 1998;
Hassig and
Lubsen, 1998)
TI Mortality Rate
(the proportion of all TI calves that will
die in one year due to BVDV)
Pert (1%,5%,52%) Expert survey
TI Case Fatality Rate
(the proportion of morbid TI calves that
will die in one year due to BVDV)
Pert (1%,7%,15%) Expert survey
TI Morbidity Rate
(the proportion of TI calves that will
become morbid due to BVDV)
Mortality Rate/Case Fatality Rate
(or 100%, if mortality rate is higher
than case fatality rate)
Expert survey
Weight lost by morbidity (kg) Normal (15.9, 3.5) Truncate (0, ) (Wittum et
al., 1994)
PI Mortality Rate
(the proportion of all PI calves that will
die in one year due to BVDV)
Pert (10%,33%,100%) Expert survey
PI Case Fatality Rate
(the proportion of morbid PI calves that
will die in one year due to BVDV)
Pert (40%,75%,100%) Expert survey
PI Morbidity Rate
(the proportion of TI calves that will
become morbid due to BVDV)
Mortality Rate/Case Fatality Rate
(or 100%, if mortality rate is higher
than case fatality rate)
Expert survey
Probability of a PI fetus due to
infection during the risk period
(vertical transmission risk)
Normal (81%, 0.7%)
Truncate (0, 1)
(Stokstad and
Loken, 2002)
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Table 5.1 (cont.)
Parameter Description Distribution Reference(s)
Probability of a deformed calf due to
infection during the risk period
Pert (3.2%,13.6%,30%) Expert survey
Duration of immunity from transient
infection
50% for 1 year, 50% for 2 years Personal opinion
Weaning weight (steers) Normal (600,10) for 60 day
breeding seasons
Normal (580,10) for 100 day
breeeding seasons
Weaning weight (heifers) Normal (590,10) for 60 day
breeding seasons
Normal (570,10) for 100 day
breeeding seasons
Cost of test (/head) Pert (2.5,4,6) Expert survey
Cost of vaccination (/head) Uniform (0.75,1.5) Expert survey
Cost of labor ($/hour) Pert (6,8,10) Expert survey
Treatment costs (/calf) Pert (4,10,15) Expert survey
1. Sensitivity analysis
1.1 Materials and Methods
Sensitivity analysis was performed on the model to determine the importance of every
distribution in Table 5.1. Sensitivity analysis on the introduction and the spread models have
been reported (chapters 3 and 4). The integrated economic model reported here was analyzed
with three combinations of the herd import profiles shown in Table 5.2 and the biosecurity
strategies in Table 5.3. The first herd is A1, a 400-head herd importing 60 non-pregnant heifers,
4 bulls, 4 calves, and 100 stockers, using no biosecurity or control program (strategy M). The
second herd is B3, a 100-head herd importing 15 pregnant heifers, 1 bull, and 100 stockers,
vaccinating all breeding animals and testing all imported animals, including stockers and the
calves of pregnant imports, and testing all calves pre-breeding (strategy Z). The third herd is C4,
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a 50-head herd importing 8 pregnant heifers and one bull every other year, testing all imports,
calves of pregnant imports, and all calves pre-breeding (strategy S). These three herds represent
a mixed selection of the herds presented in the model results.
Table 5.2: Herd import profiles used in model analysis.
Herd
number of
breeding
females
number of
heifers
imported
number of
bulls imported
number of
calves
imported
number of
stockers
imported
A1 400 60 4 4 100
A2 400 60 4 4 0
A3 400 60 4 0 100
A4 400 60 4 0 0
B1 100 15 1 1 100
B2 100 15 1 1 0
B3 100 15 1 0 100
B4 100 15 1 0 0
C1 50 8 1 every other
year
1 100
C2 50 8 1 every other
year
1 0
C3 50 8 1 every other
year
0 100
C4 50 8 1 every other
year
0 0
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Table 5.3: Biosecurity and control strategies used in model analysis; all animals in the
testing category were tested.
*adults refers to breeding animals: heifers, cows, and bulls
Sensitivity of the total 10-year cost of BVDV to each herd was modeled by fixing each of
the distributions listed in Table 5.4 individually over 2 values (low and high), as listed. The low
value was the mean minus 2 standard deviations (S.D.) for normal distributions and the
minimum value for pert distributions. The high value was the mean plus 2 S.D. for normal
distributions and the maximum value for pert distributions. This allowed the sensitivity analysis
to determine the impact of each distribution within approximately 95-100% of its expected
range. Each simulation was run for 3000 iterations with a fixed number seed. The mean cost at
each level of each distribution was calculated in @Risk. Differences between the low and high
values for cost were calculated.
Strategy
Vaccination of
breeding animals
Test
Imported
Adults*
Test Imported
Calves and
Calves of
Pregnant
Imports
Test all
calves
before
breeding
Test
Imported
Stockers
M
N X
O X
P X
Q X
R X
S X X X
T X X X X
U X X
V X X
W X X
X X X
Y X X X X
Z X X X X X
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Table 5.4: Comparison in the 10-year cost of BVDV in three herds when each input
distribution is fixed at the mean minus 2 standard deviations and at the mean plus 2
standard deviations or at the minimum and maximum value.
Difference in the 10-year cost of BVDV
with change in the input distributions
herd A1 herd B3 herd C4
Heifers not
pregnant
Heifers
pregnant Heifers pregnant
Input Distribution
Change in
Input
Distribution Strategy M Strategy Z Strategy S
Abortion Rate 1.7%-25% $14,901.14 $ 90.40 $ 34.55
Calf prevalence 0.43%-0.77% $ 1,965.98 $ 26.18 $ 24.67
EED rate 0%-32% $ 330.62 $ 0 $ 0.28
Heifer weaning weight (lb) 570-610 $ 620.71 $ 2.57 $ 1.17
Herd prevalence 4.8%-15.6% $10,417.32 $ 1.80 $ 0.62
Labor costs ($/hour) 6-10 - $ 210.61 $ 38.74
PI case fatality rate 40%-100% $ 0 $ 0 $ 0
PI mortality rate 10%-100% $ (5,643.67) $ (17.03) $ (8.24)
Probability of fenceline infection 6%-83% $14,027.64 $ 37.83 -
R0 5-12 $ 3,770.69 $ 55.23 $ 31.26
Steer weaning weight (lb) 580-620 $ 492.55 $ 1.62 $ 0.75
Test sensitivity 91.3%-97.7% - $ (121.75) $ (68.69)
TI case fatality rate 1%-15% $ (4,146.14) $ (11.56) $ (6.13)
TI Mortality Rate 1%-52% $92,267.71 $ 225.36 $ 129.38
Treatment costs/morbid calf ($) 4-15 $ 2,570.65 $ 6.22 $ 3.72
Unit cost of test ($) 2.5-6  - $7,339.97 $ 1,993.92
Unit cost of vaccination ($) 0.75-1.50 - $ 750.00 -
Vaccine Efficacy 42%-100% - $ (471.14) -
Vertical transmission rate 79.6%-82.4% $ 417.21 $ 0.59 $ 0
Weight lost by Morbidity (kg) 8.9-22.9 $ 7,166.89 $ 17.29 $ 10.33
Youngstock prevalence 0.25%-0.69% $12,498.16 $ 50.48 $ 24.51
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1.2 Results
The difference in mean cost caused by changing each distribution from the low value to
the high value is listed for the three herds in Table 5.4. In each of the herds examined, TI
mortality was one of the three most influential distributions, but the relative effect was much
higher in the 400-head herd than in the other two herds. The cost of an individual test was very
influential inputs when animals were tested (strategies S and Z), but the influence of test
sensitivity was small in comparison. The cost of a vaccine and vaccine efficacy were almost
equally influential when animals were vaccinated (strategy Z). When no biosecurity program
was used (strategy M), herd prevalence and youngstock prevalence had a large effect on mean
cost, but the prevalence distributions were less influential when testing was used (strategies S
and Z). For all three herds, an increased PI mortality rate, the proportion of all PI calves that die,
always decreased the mean cost of BVDV, but the PI case fatality rate, the proportion of PI
calves with morbidity that die, had no impact on cost.
2. Validation
2.1 Materials and Methods
Validation of the model was performed using two published outbreaks in cow-calf herds
in which the source of the virus could be determined.
The first (Taylor and Rodwell, 2001) describes the effects of BVDV for one year after
the purchase of a 269 cows by an 877 cow herd. Morbidity, mortality, the number of PIs in the
herd, and the number of lost pregnancies (due to EEDs and abortions) were tabulated and
published. The model was given the input of 269 pregnant cows imported to an 877-head naïve
herd.
The second outbreak (Campen et al., 2000) was in a 391-head herd that shared fenceline
with 3 herds and for which a subset of the outbreak herd shared pasture with a number of herds.
The number of mortalities and lost pregnancies were tabulated after one year, and a serosurvey
of all calves was performed to identify the number of TI calves. This herd was modeled to have
391 breeding animals, with 3 other herds in fenceline contact, and 2 other herds in contact on
communal pasture.
The simulation for each herd was run for 3000 iterations and the mean and standard
deviation for each of the categories in the year of introduction was calculated in @Risk. Means
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and 95% confidence intervals were calculated with the Student’s t distribution. Sensitivity
analysis was performed, as described above, for values in which the observed value was not
contained in the 95% confidence interval.
2.4 Results
The comparison between observed and predicted values for each herd are presented in
Table 5.5. For the herd that imported cows (Taylor and Rodwell, 2001), the observed values of
all variables were within the range predicted, but the mean number of mortalities predicted was
substantially less than the observed value and the mean number of lost pregnancies predicted was
substantially higher than observed. Sensitivity analysis on total morbidities after one year
indicated that a value as high as observed was most closely approached by the model mean if the
reproductive rate, R0, was fixed at its highest value, 12. Sensitivity analysis on the number of
lost pregnancies indicated that the observed value was predicted by the model mean if the
abortion rate was fixed at its 5th percentile, 1.7%. For the herd that shared both pasture and
fenceline with other herds (Campen et al., 2000), the observed values of all variables were
within the range predicted and mean predictions were similar to observed values.
Table 5.5: Comparisons of observed and predicted values from reported BVDV outbreaks
in naïve cow-calf herds
Herd output Observed value mean Lower CI Upper CI
Morbidity 265 81.51 0 319.51
Mortality 77 12.75 0 55.96
Total PIs 48 22.24 0 77.86
(Taylor and
Rodwell,
2001)
Lost pregnancies 13 78.55 0 163.47
Lost pregnancies 37 31.21 0 70.64
Infected Calves 30 29.56 0 110.41
(Campen et
al., 2000)
Mortality 1 3.92 0 17.44
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3. Model Application
3.1 Materials and Methods
The model was run for 3000 iterations with a fixed random number seed for each
of the herds listed in Table 5.2 with each of the appropriate biosecurity strategies listed in Table
3. This was a sufficient number of iterations for mean, standard deviation, and percentiles of all
outputs in all simulations to converge within 5%. For each of the herds, separate simulations
were run to model importation of pregnant heifers or importation of non-pregnant heifers. The
mean and standard deviation for total 10-year cost was calculated in @Risk. The 95%
confidence intervals around the mean were calculated with the Student’s t distribution.
Dominance graphs were built for each herd with all biosecurity strategies. In addition, the
probability of exceeding a target value for 10-year cost of BVDV in the herd was calculated with
each simulation. Calculated costs included the cost of disease and the cost of prevention and
treatment for each simulation. The target values were set as $40,000 for a 400-head herd, $7,500
for a 100-head herd, and $2,500 for a 50-head herd; these values were selected to represent the
author’s opinion of the average return to labor and management for each cow-calf herd size for
one year. The 95% confidence intervals around the probabilities were calculated with the normal
distribution Z statistic.
3.2 Results
In none of the simulations were there differences between the mean costs of any
biosecurity strategy (data not shown). First-order dominance was not observed for any herd or
for any strategy. The results of the target analysis are presented in Table 5.6 for herds importing
non-pregnant heifers and in Table 5.7 for herds importing pregnant heifers; dominant or co-
dominant strategies are in bold type for each column. Cumulative distribution functions for 3 of
the herds analyzed are shown in Figure 5.1.
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Table 5.6: Probability of exceeding target value1 of costs due to BVDV over 10 years in a
herd that imports non-pregnant heifers
5.6(a)
strategy A1 A2 A3 A4
M 45% a (42-48%) 35% a (32-38%) 40% a (37-43%) 30% a (27-32%)
N 19% bc (17-22%) 17% b (15-20%) 17% b (14-19%) 15% b (13-18%)
O 27% d (24-29%) 13% b (11-16%) 19% bc (17-22%) 5% c (4-7%)
P 41% a (38-44%) 30% a (27-33%)
Q 43% a (40-46%) 36% a (33-39%) 42%d (39-45%) 35% d (32-38%)
R 40% e (37-43%) 34% e (31-37%)
S 16% b (14-18%) 5% c (4-7%) 16% b (14-18%) 5% c (4-7%)
T 7% e (5-9%) 7% f (5-9%)
U 6% e (4-7%) 4% c (3-5%) 4% f (2-5%) 2% e (1-3%)
V 17% b (15-20%) 16% b (13-18%)
W 25% cd (22-28%) 24% d (21-26%) 23%c (21-26%) 22% f (20-25%)
X 22% b c (19-24%) 19% bc (17-22%)
Y 4% e (3-5%) 2% e (1-3%) 4% f (3-5%) 2% e (1-3%)
Z 3% e (2-5%) 3% f (2-5%)
1Target values: Herd A=$40,000
a,b,c,d,e,f,gNumbers within columns that share a superscript are not significantly different, based on
overlapping confidence intervals
Numbers in bold are the lowest risk option for that column (herd).
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5.6(b)
strategy B1 B2 B3 B4
M 38% a (35-41%) 22% a (20-25%) 37% a (34-40%) 20% a (18-22%)
N 15% b (13-17%) 12% b (10-14%) 14% b (12-16%) 12% b (10-14%)
O 26% c (23-29%) 5% c (3-6%) 24% c (21-26%) 2% c (1-2%)
P 37% a (34-40%) 20% a (18-23%)
Q 40% a (37-43%) 26% a (23-29%) 39% a (36-42%) 25% d (23-28%)
R 31% d (29-34%) 28% d (26-31%)
S 23% c (21-26%) 2% d (1-3%) 23% c (21-26%) 2% c (1-3%)
T 100% e 100% e
U 5% f (3-6%) 2% d (1-3%) 4% f (2-5%) 1% c (0-1%)
V 14% b (12-17%) 12% b (10-14%)
W 26% c (24-29%) 23% a (20-26%) 26% c d (23-28%) 22% a d (20-25%)
X 27% c d (25-30%) 25% c d (22-28%)
Y 8% g (6-9%) 2% d (1-3%) 7% g (6-9%) 2% c (1-3%)
Z 100% e 100% e
1Target values: Herd B=$7,500
a,b,c,d,e,f,gNumbers within columns that share a superscript are not significantly different, based on
overlapping confidence intervals
Numbers in bold are the lowest risk option for that column (herd).
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5.6(c)
strategy C1 C2 C3 C4
M 43% a (40-46%) 17% a (14-19%) 41%a (38-44%) 13%a (11-16%)
N 20% b (17-22%) 11% b (9-13%) 18% b (15-20%) 9%b (8-11%)
O 36% c (33-39%) 5% c (4-7%) 34% c (31-37%) 1%c (1-2%)
P 41% a c (38-44%) 14% a b (11-16%)
Q 56% d (53-59%) 18% a (16-20%) 54% d (51-57%) 15% a (13-17%)
R 100% e 100% e
S 67% f (64-70%) 23% d (21-26%) 67% f (64-70%) 23%d (20-26%)
T 100% e 100% e
U 14% g (12-16%) 4% c (3-5%) 11% g (9-13%) 1% c (0-2%)
V 18% b (16-20%) 10% b (8-11%)
W 96% h (95-97%) 93% e (92-95%) 96% h (95-97%) 93%e (92-95%)
X 100% e 100% e
Y 100% e 100% f 100% e 100%f
Z 100% e 100% e
1Target values: Herd C=$2,500
a,b,c,d,e,f,gNumbers within columns that share a superscript are not significantly different, based on
overlapping confidence intervals
Numbers in bold are the lowest risk option for that column (herd).
88
Table 5.7: Probability of exceeding target value1 of costs due to BVDV over 10 years in a
herd that imports pregnant heifers
5.7(a)
strategy A1 A2 A3 A4
M 74%a (71-77%) 70% a (67-73%) 73% a (70-76%) 69% a (66-71%)
N 44% bc (41-48%) 43% b (40-46%) 43% b (40-46%) 41% bc (38-45%)
O 75% a (72-77%) 71% a (68-74%) 74% a (71-76%) 69% a (67-72%)
P 43% b (40-46%) 33% c (30-36%) 42% b (39-45%) 32%d (29-35%)
Q 55% d (52-58%) 48% b (45-51%) 54% c (51-57%) 47% b (44-50%)
R 76% a (73-79%) 75% a (72-77%)
S 17% e (15-20%) 7% d (5-8%) 17% d (15-20%) 7%e (5-8%)
T 9% f (7-10%) 9% e (7-10%)
U 45% bc (42-48%) 43% b (40-46%) 43% b (39-46%) 41% bc (38-44%)
V 18% e (16-21%) 17% e (14-19%) 18% d (16-21%) 16%f (14-19%)
W 38% b (35-41%) 37% c (34-40%) 37% b (34-40%) 36%cd (33-39%)
X 50% c (47-53%) 48% b (45-51%)
Y 5% g (4-7%) 4% f (3-5%) 5% f (4-7%) 4%g (3-5%)
Z 5% g (4-7%) 5% f (4-7%)
1Target values: Herd A=$40,000
a,b,c,d,e,f,gNumbers within columns that share a superscript are not significantly different, based on
overlapping confidence intervals
Numbers in bold are the lowest risk option for that column (herd).
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5.7(b)
strategy B1 B2 B3 B4
M 57%ab (53-60%) 45% a (42-48%) 55% ab (52-58%) 43% a (40-46%)
N 27% c (25-30%) 24% bc (22-27%) 27% cd (24-29%) 23% bc (21-26%)
O 57% ab (54-60%) 45% a (42-48%) 56% ab (53-59%) 43% a (40-46%)
P 38% d (35-41%) 20% b (17-22%) 37% e (34-40%) 19% b (17-22%)
Q 48% e (45-51%) 32% d (29-35%) 47% f (44-50%) 31% d (28-34%)
R 59% a (56-62%) 57% a (54-60%)
S 24% c (21-27%) 3% e (2-4%) 24% c (21-27%) 3% e (2-4%)
T 100% f 100% g
U 28% c (25-30%) 23% bc (21-26%) 27% cd (24-29%) 23% bc (20-25%)
V 15% g (13-17%) 12% (10-14%) 15% h (13-17%) 12% f (10-14%)
W 32% c (29-35%) 27% cd (25-30%) 31% d (28-34%) 27% cd (24-29%)
X 52% be (49-55%) 50% bf (47-53%)
Y 8% h (7-10%) 3% e (2-4%) 8% I (7-10%) 3% e (2-4%)
Z 100% f 100% g
1Target values: Herd B=$7,500
a,b,c,d,e,f,gNumbers within columns that share a superscript are not significantly different, based on
overlapping confidence intervals
Numbers in bold are the lowest risk option for that column (herd).
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5.7(c)
strategy C1 C2 C3 C4
M 57% a (54-60%) 38% a (35-41%) 56% a (53-59%) 35% a (32-38%)
N 33% b (30-36%) 25% b (23-28%) 32% b (29-35%) 24% b (21-27%)
O 58% a (55-61%) 37% a (34-40%) 57% a (54-60%) 34% a (31-37%)
P 43% c (40-46%) 14% c (11-16%) 43% c (39-46%) 13% c (11-15%)
Q 68% d (65-71%) 39% a (36-42%) 67% d (64-70%) 37% a (34-40%)
R 100% e 100% e
S 68% d (65-71%) 25% b (22-28%) 68% d (65-71%) 25% b (22-27%)
T 100% e 100% e
U 36% b (33-39%) 27% b (24-30%) 34% b (31-37%) 25% b (22-28%)
V 20% f (18-23%) 11% c (9-12%) 20% f (17-22%) 10% c (8-12%)
W 97% g (96-98%) 95% d (94-96%) 97% g (96-98%) 95% d (93-96%)
X 100% e 100% e
Y 100% e 100% e 100% e 100% e
Z 100% e 100% e
1Target values: Herd C=$2,500
a,b,c,d,e,f,gNumbers within columns that share a superscript are not significantly different, based on
overlapping confidence intervals
Numbers in bold are the lowest risk option for that column (herd).
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Figure 5.1: Cumulative distribution functions for 10-year cost due to BVDV with selected
biosecurity strategies.
5.1(a): A 400-head herd importing 60 non-pregnant heifers, 4 bulls, 4 calves, and 100 stockers
annually.
Cumulative distribution for total 10-year cost of BVDV in herd A1, importing non-pregnant
heifers
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Strategy: M (do nothing), N (vaccinate breeding animals), S (test imported heifers, bulls,
and calves and test and cull all calves in the herd pre-breeding), T (test all imports, including
stockers, and test and cull all calves in the herd pre-breeding), U (vaccinate breeding animals and
test imported heifers and bulls), Y (test as in S and vaccinate breeding animals), Z (test as in T
and vaccinate breeding animals)
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5.1(b): A 100-head herd importing 15 pregnant heifers, 1 bull, and 100 stockers annually.
Cumulative distribution for total 10-year cost of BVDV in herd B3, importing pregnant
heifers
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Strategy: M (do nothing), N (vaccinate breeding animals), S (test imported heifers, bulls, calves,
and calves of pregnant imports and test and cull all calves in the herd pre-breeding), T (test all
imports, including stockers, and test and cull all calves in the herd pre-breeding), V (vaccinate
breeding animals and test imported calves and calves of pregnant imports), Y (test as in S and
vaccinate breeding animals), Z (test as in T and vaccinate breeding animals)
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5.1(c): A 50-head herd importing 8 pregnant heifers annually and 1 bull every other year.
Cumulative distribution for total 10-year cost of BVDV in herd C4, importing pregnant
heifers
0
0.2
0.4
0.6
0.8
1
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
Cost (in thousands of dollars)
pr
o
ba
bi
lit
y
o
fe
x
ce
ed
in
g
th
e
x
-
a
x
is
v
a
lu
e
Strategy
M
N
P
S
V
Y
Strategy: M (do nothing), N (vaccinate breeding animals), P (test calves of pregnant imports), S
(test imported heifers, bulls, and calves and test and cull all calves in the herd pre-breeding), V
(vaccinate breeding animals and test calves of pregnant imports), Y (test as in S and vaccinate
breeding animals)
Discussion
The model presented here predicts the economic risks associated with specific
management decisions as regards BVDV, including the importation of different classes of cattle
and biosecurity strategies. While the model does not predict, in a deterministic sense, the most
cost-effective strategy for BVDV, it does give herd-specific risk calculations that can assist in
decision making allowing the individual producer to include their individual risk preferences into
the decision making process. The outcome utilized is based on the probability of exceeding a
target value of cost to account for both the costs of disease and prevention. This allows decision
making based on the cost of disease and the effectiveness and cost of mitigation.
Validation of a stochastic disease model with field data is an accepted method
(Cleveland, 2003; Viet et al., 2004a). However, field data is either available from endemically
infected herds, for which this model is not designed, or from outbreaks, in which the source of
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virus is not often known. Only two published outbreak reports were found to be sufficiently
detailed for validation of this model, and a limited number of effects were recorded for each.
With the observations available for each herd, the model was able to predict an outcome not
significantly different from the observed value for all variables. In one validation (Taylor) we
substantially underestimated the number of morbidities but the subsequent sensitivity analysis
indicated that a high R0 resolved the difference. It seems reasonable that this outbreak may have
experience an elevated R0, accounting for the increase in morbidities. It is known that the
reproductive rate of a virus may vary with strain, animal density, nutritional status of the
animals, and other management factors (Dohoo et al., 2003). It is quite possible that a
publication bias towards larger outbreaks leads to outbreaks in the published literature being
those in which the R0 was higher than average. In that case, the inability of the model to predict
the outcome of the outbreak perfectly is to be expected. In the case of the number of lost
pregnancies, in which the model over-predicted the mean compared to that reported by Taylor
and Rodwell, sensitivity analysis indicated that a low-end value for the abortion rate (1.7%)
would cause the model to predict the observed number of lost pregnancies. Abortion rate is also
a distribution that may involve natural variability, so it is possible that the strain involved in the
reported outbreak was less likely to cause abortions than other strains observed in the literature
that provided the distribution. If the model is run with the R0 fixed at 12 and the abortion rate
fixed at 1.7%, the discrepancy in the number of lost pregnancies decreases by 99% (from 78 to
12 predicted lost pregnancies, compared to the 13 observed) and the discrepancy between
observed and predicted calf morbidity decreases by 10% (from 81 to 112 predicted morbidities,
compared to 265 observed). However, given the large numbers of other transient infections in
this outbreak (calf morbidity and mortality), it seems unlikely that this strain was less virulent
than normal in regards to the abortion rate. Another possible explanation for the model’s over-
prediction is that the observed value from the outbreak is an estimate based on the difference
between the herd’s average calving rate and the calving rate after the outbreak. As this is an
estimate it is possible that more pregnancies were lost due to BVDV than reported which would
be more consistent with the model’s predictions.
The sensitivity analysis of the integrated model gives some intriguing results (Table 4).
The impact of the distributions used in the model indicates that it is the variability around the
biological factors that are most influential in the model, and that most economic factors, such as
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the cost of labor, the cost of treatment, and the weaning weight or heifers or steers, rarely impact
the overall cost of BVDV. The exception is the cost of testing, which is the most influential
distribution if animals are tested, and the cost of vaccination, which is influential when animals
are vaccinated. When testing strategies are used, a $2 increase in the cost of a test leads to a
mean cost increase of $4,193 in a 100-head herd testing 131 imports and close to 100 calves
every year, while the same increase leads to a mean cost increase of $1,139 in a 50-head herd
testing 17 imports and close to 50 calves every year; this is 0.6% and 0.5% of expected return to
labor and management over 10 years, respectively. The impact of increasing the cost of vaccine
by $0.75 was only one-fifth as large, but that is likely due in part to the fact that many more
animals were tested than were vaccinated with the biosecurity strategy used. These findings
would indicate that the cost of the test and the vaccine would have a substantial impact on the
choice of biosecurity strategy. The cost of the vaccine is not correlated with the vaccine
efficacy, which is almost an equally influential variable; a more expensive vaccine that is more
efficacious could be cost-effective. Vaccine efficacy is also a distribution incorporating
substantial natural variability. Published estimates of vaccine efficacy in preventing PIs vary
considerably. Some of this variability may be due to differences between vaccines but some also
may be due to differences in the specifics of the trials related to cattle factors and viral challenge
factors. In a production setting, additional variability exists due to vaccine handling and
management of cattle that may affect their ability to mount an effective immune response. The
model attempts to capture some of the variation seen with different vaccines, their performance
against different strains of BVDV, and the management factors that affect their efficacy.
The biological variable shown to be most influential is the TI mortality rate. This
distribution is particularly wide, but it is a pert distribution with a long tail to the right, so the
maximum value used in the sensitivity analysis would rarely be used. Surveyed experts believed
based on their personal experience in cow-calf herds experiencing outbreaks that while TI
mortality rates were generally modest, in some cases high mortality rates were observed. This
phenomenon may be due to variability seen in BVDV strains, so these distributions are
appropriately wide and influential in the model. The distribution was more influential when no
control strategy was used (herd A1); this herd would experience more TIs over 10 years, which
would explain the greater influence of the TI mortality rate. Herd prevalence and youngstock
prevalence were also very influential if no testing strategy was used. The influence of
96
youngstock prevalence is likely due to the large number of youngstock imports (stockers, heifers,
and bulls) in herds modeled here, while increased herd prevalence would decrease the clustering
of PI heifers, allowing for a more constant introduction of virus to maintain high infection levels
in the herd. If animals were tested, the effect of prevalence values is substantially decreased.
The sensitivity analysis also showed that an increase in the PI mortality rate decreased the
mean cost of BVDV for all herds scenarios examined. In contrast, variation in the PI case
fatality rate, which is used to calculate the PI morbidity rate, never impacted the mean cost.
Anecdotal evidence has long suggested that the best thing a PI calf could do, in a cow-calf herd
or in a feedlot, would be to die young, thus removing itself as a source of infection and
preventing ongoing costs associated with feed and morbidity. This finding supports that view; as
PI mortality is calculated every three weeks within the SIR model, a high mortality rate causes
the PIs to be removed from the model quickly, protecting the other animals in the herd from
transient infections. In comparison, the relatively small numbers of PI calves prevents PI
morbidities, which are calculate via the PI case fatality rate, to have a large effect on total cost
compared to TI morbidities.
The predictions of the model with regards to cost show no significant differences
between biosecurity strategies in mean cost of BVDV over 10 years and no first-order
dominance in descending probability cost distributions, regardless of the herd modeled. This is
related to the low prevalence of PIs resulting in introduction of a PI being a rare event. With a
rare outcome, the mean cost of the disease is skewed to the left, obscuring differences in control
programs. This was the primary reason to build a stochastic model for BVDV, so these results
are not unexpected.
When mean differences are not significantly different, and when first-order dominance
does not occur, decisions must be made based on other criteria. The results presented here,
based on the probability of exceeding a target value, are only one method of risk-based decision
making. Target analysis is an intuitive method for decision making in cow-calf production
enterprises.
It can be seen, looking at Tables 6 and 7, that herd size and import profile are important
determinants in the risk of exceeding the target cost. Comparing tables 6 and 7, herds importing
pregnant heifers have a significantly higher probability of exceeding the target cost than herds
importing non-pregnant heifers if no biosecurity strategy is employed (strategy M). Testing
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adult imports (heifers and bulls) only (strategy O) decreases risk compared to doing nothing
(strategy M) only in herds importing non-pregnant heifers, and is only co-dominant in the 50-
head herds importing non-pregnant heifers and no stockers (herds C2 and C4) or the 100-head
herds importing only non-pregnant adults (heifers and bulls, herd B4). Pregnant heifers may be
PI and carrying a PI calf, but alternately they may have been transiently infected during the risk
period and be carrying a PI calf. A testing strategy that only tests the replacement heifers would
miss the PI calf of a previously TI heifer and allow introduction of BVDV to the herd.
Conversely testing the calves of pregnant imports after birth and before breeding season will
allow detection of the calf and identification of the dam for further testing. In this model, the
dams of positive calves are not tested unless all the replacement heifers are tested, but the calves
of positive dams are automatically removed. Calves and fetal imports, are a proportionately
greater risk to the herd than their dams because the risk associated with imports increases as the
age of the imports decreases, due to higher PI prevalence in younger animals.
Regardless of the other import decisions, importing stockers increases the risk of
exceeding the target cost. This assumes there is fenceline contact between the breeding herd and
the stockers. In U.S. beef production systems, stockers may be imported at relatively high rates
into a breeding herd to take advantage of additional grazing or as a market risk management
option. The number of stockers modeled here represents approximately 1 truckload of stockers
and is meant to be representative of the lower end of potential import rates. Vaccinating
breeding animals and testing adult imports, including stockers (strategy U), is always one of the
lowest risk strategies if stockers and non-pregnant heifers are imported. If imported heifers are
pregnant, however, a combination of vaccinating and testing the imported calves and calves of
pregnant imports (strategy V) is dominant for 50-head herds, while for 100-head herds a
combination of vaccination, testing all imports except stockers, and testing and culling calves
pre-breeding is dominant (strategy Y). In the 400-head herd importing stockers and pregnant
heifers, co-dominance is observed between strategy Y and strategy Z, which adds the testing of
imported stockers. Testing the imported stockers decreases the risk of importing PI stockers, but
the cost of testing stockers is greater than the target value for 50-head herds and the cost of
combining stocker testing with the other testing strategies (strategies T and Z) is greater than the
target value for 100-head herds. Because the base cost of testing stockers is so high, it is only
among the lowest-risk options for 400-head herds, where it is co-dominant with less expensive
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strategies. If management allows, the most cost effective management of the risk due to stockers
may be to assure that there is no contact between the imported stockers and the breeding herd,
which would be comparable to the herds in these results that did not import stockers.
In the absence of stockers, vaccination of breeding animals as a single biosecurity
practice is only necessary to decrease risk in the 400-head herd, although it is among the co-
dominant options for all herds, and vaccination alone decreases risk compared to doing nothing.
Instead, testing without vaccination becomes co-dominant. When imported heifers are not
pregnant and few or no calves are imported, testing only adults (strategy O) is the lowest-cost co-
dominant option for 50- and 100-head herds. If pregnant heifers are imported, however, both 50-
and 100- head herds require testing of imported calves, alone or in combination with other
strategies. Based on the results of this model, it would be advisable for smaller herds whose risk
is based on importation of animals to the breeding herd, rather than stockers, to implement
testing strategies rather than vaccination. In larger herds and herds that imported stockers, a
strategy that included vaccination was always dominant or co-dominant. Herds that import
stockers or large numbers of other animals should consider a vaccination strategy. Similarly,
herds that have contact with other herds on fencelines or communal pastures have introduction
risk that cannot be controlled by testing and should consider a vaccination strategy.
In the 50- and 100-head herds, strategies combining vaccination and/or large amounts of
testing (strategies T and Z) cost more than the target value specified. While these strategies may
decrease the risk of introducing and spreading BVDV in the herd, they do not appear to be cost-
effective in the long term. A more judicious use of targeted testing, with vaccination when
necessary, appears preferable from an economic standpoint.
The results presented in Tables 6 and 7, although useful, are limited to a single target
value. While this is useful for decision making if the target value is known, different producers
may have different levels of acceptable risk, whereupon cumulative distribution functions
(CDFs) become useful. In Figure 1(a), it can be seen that the risk of an outbreak exceeding any
cost target value between $10,000 and $25,000 in that particular herd is lowest if strategy U
(vaccinating breeding animals and testing imported adults) is used. Above $25,000, the risk of
exceeding the target is lowest with the addition of testing imported stockers (strategies T and Z)
and/or testing and culling calves pre-breeding (strategies Y and Z). The base cost of these
programs is greater, but they provide more protection; a risk-adverse producer may choose to use
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the more expensive strategy, while another producer may find the increased risk of large costs
acceptable in exchange for a less-expensive base cost.
In Figure 1(b), there are primarily two dominant biosecurity strategies evident for herd
B3. The less expensive strategy is vaccinating breeding animals and testing imported calves,
including the calves of the pregnant imported heifers (strategy V). Additional protection from
risk of large outbreaks comes with also testing adult imports and testing and culling calves pre-
breeding (strategy Y), but the base cost is higher. For herd C4 (Figure 1(c)), testing only the
calves of pregnant imports (strategy P) is dominant at low cost levels, but testing the adult
imports and testing and culling the calves pre-breeding, as well (strategy S), is necessary to
minimize the risk of outbreaks exceeding $2,700. Again, the choice of a biosecurity strategy
depends on the willingness of the producer to accept either the increased risk of a larger outbreak
or the increased cost of a more expensive strategy.
The results presented here are specific to the herd profiles used to obtain them and
indicate that the most cost effective biosecurity plan should be designed for the specific risks of
the herd. While generalizations may be made, it is preferable to model herds on an individual
basis. However, the results presented here suggest that for smaller herds with modest import
rates, strategic testing of imports is the most cost-effective way to exclude BVDV and control
losses. For herds with larger numbers of breeding animals and/or some level of uncontrolled
risk, such as exposure to stockers or neighboring herds, vaccination of the breeding herd may be
a cost-effective addition to strategic testing strategies.
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Appendix A - Critical Literature Review Checklists
The checklists used to evaluate literature during the critical review are included below.
Categorization of each study was based on the author’s opinion. Hybrid studies were analyzed
based on the criteria pertinent to each study.
Cross-sectional Studies
• objectives stated adequately
• sample size justified
• groups representative of field conditions
• reason operations declined described
• methods of cooperator recruitment and cooperators described
• animal or pen selection described and justified
• intervention protocols or exposure variable described
• appropriate comparison or control group used
• intervention or exposure assessed equally for cases and controls
• adequate lab tests to determine outcome used
• time from intervention to outcome measurement sufficient
• mortality, withdrawals, lost to follow up reported
• proportion of lost to follow up adequate
• stats analysis appropriate
• estimates and measures of variability used presented adequately
• confounders appropriately considered
• conclusions supported by results
Case-Control Studies
• objectives stated adequately
• sample size justified
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• groups representative of field conditions
• reason operations declined described
• methods of selecting case and controls described
• cases and controls similar with equal exposure opportunity
• animal or pen selection described and justified
• intervention protocols or exposure variable described
• appropriate comparison or control group used
• intervention or exposure assessed equally for cases and controls
• adequate lab tests to determine outcome used
• time from intervention to outcome measurement sufficient
• mortality, withdrawals, lost to follow up reported
• proportion of lost to follow up adequate
• stats analysis appropriate
• estimates and measures of variability used presented adequately
• confounders appropriately considered
• conclusions supported by results
Cohort Studies
• objectives stated adequately
• sample size justified
• groups representative of field conditions
• reason operations declined described
• methods of cooperator recruitment and cooperators described
• animal or pen selection described and justified
• intervention protocols or exposure variable described
• appropriate comparison or control group used
• route, schedule, grouping of intervention commercially feasible
• outcome assessor blinded to intervention status of units
• adequate lab tests to determine outcome used
• time from intervention to outcome measurement sufficient
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• clinically relevant outcome
• mortality, withdrawals, lost to follow up reported
• proportion of lost to follow up adequate
• stats analysis appropriate
• estimates and measures of variability used presented adequately
• confounders appropriately considered
• conclusions supported by results
Randomized Clinical Trials
• objectives stated adequately
• sample size justified
• groups representative of field conditions
• reason operations declined described
• methods of selecting case and controls described
• methods of cooperator recruitment and cooperators described
• intervention protocols or exposure variable described
• appropriate comparison or control group used
• descriptive stats support valid randomization, numbers per group
• sampling units randomly assigned to the treatment groups
• sampling units tested for outcome prior to intervention
• route, schedule, grouping of intervention commercially feasible
• outcome assessor blinded to intervention status of units
• adequate lab tests to determine outcome used
• time from intervention to outcome measurement sufficient
• clinically relevant outcome
• mortality, withdrawals, lost to follow up reported
• proportion of lost to follow up adequate
• stats analysis appropriate
• estimates and measures of variability used presented adequately
• confounders appropriately considered
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• conclusions supported by results
Challenge Trials
• objectives stated adequately
• sample size justified
• intervention protocols or exposure variable described
• appropriate comparison or control group used
• descriptive stats support valid randomization, numbers per group
• sampling units randomly assigned to the treatment groups
• sampling units tested for outcome prior to intervention
• route, schedule, grouping of intervention commercially feasible
• outcome assessor blinded to intervention status of units
• adequate lab tests to determine outcome used
• time from intervention to outcome measurement sufficient
• mortality, withdrawals, lost to follow up reported
• proportion of lost to follow up adequate
• stats analysis appropriate
• estimates and measures of variability used presented adequately
• confounders appropriately considered
• conclusions supported by results
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Appendix B - Assumptions of the Model
The model presented in chapters 3-5 makes several assumptions, either for the sake of
simplicity or where no data is available.
Assumptions for Introduction (Chapter 3)
• All heifers are assumed to be imported from a single herd, allowing for clustering
of PIs.
• Pregnant imports that are PIs are assumed to give birth to PI calves.
• When PI calves are detected among the calves of pregnant imports, it is assumed
that their dams will be tested. If any pregnant imports are PIs, they will be
included in this testing.
• Animals are assumed to be kept in perfect quarantine before test results are
available.
• Test specificity is assumed to be 100%.
Assumptions for Spread (Chapter 4)
• PIs are the only source of infection; horizontal transmission cannot occur from
TIs.
• PI mortality is assumed to occur randomly in the period between calving and
weaning.
• Calves of resistant dams are assumed to be resistant from birth to weaning.
• Conception rate is assumed to be 65% per 3-week period for herds with a 60-day
breeding season and 50% per 3-week period for herds with a 100-day breeding
season.
• All births, deaths, infections, and conceptions are assumed to occur on day 1 of
the 3-week period in which they occur.
• EED’s are assumed to occur according to the distribution in Table 5.1 to dams
transiently infected between 1 to 42 days gestation.
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o When EED’s occur before the last breeding cycle, the dam is assumed to
be available for re-breeding.
• PI’s are assumed to occur according to the distribution in Table 5.1 to dams
transiently infected between 43 to 126 days gestation.
• Fetal malformations are assumed to occur according to the distribution in Table
5.1 to dams transiently infected between 127 days gestation and weaning (252
days after the beginning of calving).
• Abortions are assumed to occur according to the distribution in Table 5.1 to all
dams transiently infected on an annual basis.
• PI heifers born in the herd are assumed to be retained at 30% the rate of retention
in all heifers.
• Mortality (for both TIs and PIs) is assumed to occur only in morbid animals.
o Morbidity is assumed to be 100% if the mortality rate is larger than the
case fatality rate.
• Resistance from vaccination is assumed to last one year
o Resistance from transient infection is assumed to last 1 year in 50% of TI
animals, and 2 years in the remainder of TIs.
o Resistance from transient infection is assumed to be total; it is assumed
that the strain of BVDV will not be different from year to year.
Assumptions for Economic Analysis (Chapter 5)
• Infection from fenceline contact resulted in a single PI present within the breeding
herd for a 3-week period. The time of the infection was modeled randomly within
the period between calving and weaning.
o It is assumed that the R0 will be lower (Table 5.1) if the infection is due
only to fenceline contact, but the R0 will be chosen from the higher
distribution if infection is present in the herd from any other source.
• Imported PI fetuses are randomly assigned to birth in 3-week periods during the
calving season.
• All other PI imports are assumed to be added to the herd on the first day of the
calving season.
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• Treatment cost is applied to all morbidities.
• Labor costs are based on hourly costs.
o Vaccination is assumed to require 0.033 hours (2 minutes) per animal in
herds of 50 head, 0.017 hours (1 minute) per animal in herds of 51-100
head, and 0.008 hours (1/2 minute) per animal in herds of >100 head.
o Testing is assumed to require 0.017 hours (1 minute) per animal in all
herds.
• Weaning weights for steers and heifers are strongly correlated in each year.
• The price draws for steers and heifers are strongly correlated within each year, as
are the price draws between weaning weights.
• In the results presented here, it is assumed that calves are marketed at weaning
and that weaning occurs in September.
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Appendix C - Expert Survey Questionnaire
The following questionnaire was sent to 5 expert DVMs in the field of BVDV. Their
responses were averaged to provide the parameters for pert distributions. Input distributions that
were referenced to expert opinion and are not included in this list were defined in a workshop
with 4 expert DVMs in cow-calf herd health management.
Dear Dr ___
As part of a Master’s degree here at Kansas State University I am building a risk analysis
model for BVD biosecurity on cow-calf farms in the US, incorporating both the risk of importing
BVD and the impact it will have on individual herds, based on their management practices. In
the course of the literature review, a number of holes in our understanding of BVDV
transmission were noted.
Please take a moment to answer any or all of these questions below based on your
experience with BVDV. For each question, it would be useful to have estimates for the
minimum, maximum, and most likely values.
Please fill in the blanks below and return to the email address below.
Thank you very much for your time and expertise
Becky Smith DVM (rebecca.lee.smith@gmail.com),
Mike Sanderson DVM, MS DACVPM (Epidemiology)
1. What is the PI mortality rate:
a. from birth to 60 days (What proportion of PI calves die between birth and 60 days of
age?) 
i. minimum:
ii. maximum:
iii. most likely:
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b. from 60 days to weaning (What proportion of PI calves die between 60 days of age and
weaning?)
i. minimum:
ii. maximum:
iii. most likely:
c. from weaning to 45 days post-weaning (What proportion of PI calves die between
weaning and 45 days post weaning?)
i. minimum:
ii. maximum:
iii. most likely:
2. What is the percent increase in morbidity rate in non-PI calves when PIs are present in a
herd?
i. minimum:
ii. maximum:
iii. most likely:
3. What is the percent increase in mortality rate in non-PI calves when PIs are present in a
herd?
i. minimum:
ii. maximum:
iii. most likely:
4. Among dams infected before 45 days gestation, what is the proportion of early embryonic
deaths?
i. minimum:
ii. maximum:
iii. most likely:
5. Among dams infected after 125 days gestation, what is the congenital defect rate in
calves?
i. minimum:
ii. maximum:
iii. most likely:
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6. What is the probability of infection from fenceline contact with neighboring infected
herds?
i. minimum:
ii. maximum:
iii. most likely:
7. How many susceptible animals will be infected by a single PI in the herd over a 21-day
period?
i. minimum:
ii. maximum:
iii. most likely:
b. Is it different for PIs with fenceline contact? If so, what is the number infected?
i. minimum:
ii. maximum:
iii. most likely:
8. What is the proportion of susceptible dams that will abort in a year from BVD infection if
BVD is present in the herd?
i. minimum:
ii. maximum:
iii. most likely:
